Atlas Financial (AFHIF) 10-K 31 Mar 22 2021 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Mar. 30, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K
Document Period End Date	Dec. 31, 2021
Current Fiscal Year End Date	--12-31
Entity File Number	000-54627
Entity Registrant Name	ATLAS FINANCIAL HOLDINGS, INC.
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	27-5466079
Entity Address, Address Line One	953 American Lane
Entity Address, Address Line Two	3rd Floor
Entity Address, City or Town	Schaumburg
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60173
Local Phone Number	847
City Area Code	472-6700
Title of 12(g) Security	Common, $0.003 par value per share
Trading Symbol	AFHIQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		17,297,334
Entity Public Float			$ 4.9
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates by reference certain information that will be contained in Atlas Financial Holdings, Inc.’s Proxy Statement relating to its 2022 Annual General Meeting of Shareholders, which Atlas Financial Holdings, Inc. intends to file no later than 120 days after the end of its fiscal year ended December 31, 2021, and thus these items have been omitted in accordance with General Instruction G(3) to Form 10-K.
Document Annual Report	true
Document Transition Report	false
Entity Central Index Key	0001539894
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2021
Audit Information [Abstract]
Auditor Firm ID	23
Auditor Name	Baker Tilly US, LLP
Auditor Location	Milwaukee, Wisconsin

Consolidated Statements of Fina

Consolidated Statements of Financial Position - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Assets
Cash and cash equivalents	$ 2,274	$ 5,238
Restricted cash	3,637	5,287
Premiums receivable (net of allowance of $225 and $800, respectively)	11,397	13,442
Intangible assets, net	983	2,235
Property and equipment, net	2,503	18,815
Right-of-use asset	237	888
Notes receivable	18,017	18,017
Credit facility fees, net	584	0
Other assets	1,053	1,895
Assets held for sale	7,500	53,885
Total assets	48,185	119,702
Liabilities
Premiums payable	13,593	19,416
Lease liability	224	1,091
Due to deconsolidated affiliates	19,957	19,170
Notes payable, net	33,102	36,168
Other liabilities and accrued expenses	6,811	4,342
Liabilities held for sale	0	60,407
Total liabilities	73,687	140,594
Commitments and contingencies (See Note 7)
Shareholders’ deficit
Additional paid-in capital	83,086	81,840
Treasury stock, at cost: 255,505 shares of ordinary common voting shares at December 31, 2021 and December 31, 2020, respectively	(3,000)	(3,000)
Retained deficit	(105,633)	(100,199)
Accumulated other comprehensive income, net of tax	0	430
Total shareholders' deficit	(25,502)	(20,892)
Total liabilities and shareholders' deficit	48,185	119,702
Ordinary voting common shares
Shareholders’ deficit
Ordinary voting common shares, $0.003 par value, 800,000,001 shares authorized, shares issued: December 31, 2021 - 15,052,839 and December 31, 2020 - 12,248,798; shares outstanding: December 31, 2021 - 14,797,334 and December 31, 2020 - 11,993,293	45	37
Restricted Voting Common Shares
Shareholders’ deficit
Restricted voting common shares, $0.003 par value, 33,333,334 shares authorized, shares issued and outstanding: December 31, 2021 and December 31, 2020 - 0	$ 0	$ 0

Consolidated Statements of Fi_2

Consolidated Statements of Financial Position (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Premium receivable, allowance	$ 225	$ 800
Shareholders’ deficit
Common shares, shares authorized (in shares)	833,333,335
Common shares, shares issued (in shares)	15,052,839	12,248,798
Common stock, shares, outstanding (in shares)	14,797,334	11,993,293
Ordinary voting common shares
Shareholders’ deficit
Common shares, par value (USD per share)	$ 0.003	$ 0.003
Common shares, shares authorized (in shares)	800,000,001	800,000,001
Common shares, shares issued (in shares)	15,052,839	12,248,798
Common stock, shares, outstanding (in shares)	14,797,334	11,993,293
Treasury stock, common (in shares)	255,505	255,505
Restricted Voting Common Shares
Shareholders’ deficit
Common shares, par value (USD per share)	$ 0.003	$ 0.003
Common shares, shares authorized (in shares)	33,333,334	33,333,334
Common shares, shares issued (in shares)	0	0
Common stock, shares, outstanding (in shares)	0	0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Commission income	$ 5,923	$ 5,195
Net realized losses	(6,952)	(3)
Other income	5,867	4,354
Total revenue	4,838	9,546
Acquisition costs	3,165	2,934
Other underwriting expenses	16,279	17,743
Amortization of intangible assets	322	390
Interest expense, net	2,235	1,931
Impairment of intangible assets	930	0
Forgiveness of Paycheck Protection Program loan	6,601	0
Gain on disposal of subsidiaries	(5,659)	0
Total expenses	10,671	22,998
Loss from operations before income taxes	(5,833)	(13,452)
Income tax benefit	0	(484)
Loss from continuing operations	(5,833)	(12,968)
Income from discontinued operations, net of tax	165	238
Net loss	$ (5,668)	$ (12,730)
Basic net income (loss) per share attributable to common shareholders
Continuing operations (in dollars per share)	$ (0.45)	$ (1.08)
Discontinued operations (in dollars per share)	0.01	0.02
Net loss (in dollars per share)	(0.44)	(1.06)
Diluted net income (loss) per share attributable to common shareholders
Continuing operations (in dollars per share)	(0.45)	(1.08)
Discontinued operations (in dollars per share)	0.01	0.02
Net loss (in dollars per share)	$ (0.44)	$ (1.06)
Basic weighted average common shares outstanding (in shares)	12,960,674	11,957,268
Diluted weighted average common shares outstanding (in shares)	12,960,674	11,957,268
Consolidated Statements of Comprehensive Income (Loss)
Net loss	$ (5,668)	$ (12,730)
Other comprehensive (loss) income:
Changes in net unrealized investment (losses) gains	(21)	161
Reclassification to net loss	(175)	(155)
Other comprehensive (loss) income	(196)	6
Total comprehensive loss	$ (5,864)	$ (12,724)

Consolidated Statements of Shar

Consolidated Statements of Shareholders' (Deficit) Equity - USD ($) $ in Thousands	Total	Ordinary Voting Common Shares	Restricted Voting Common Shares	Additional Paid-In Capital	Treasury Stock	Retained Deficit	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period at Dec. 31, 2019	$ (8,461)	$ 36	$ 0	$ 81,548	$ (3,000)	$ (87,469)	$ 424
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(12,730)					(12,730)
Other comprehensive income	6						6
Share-based compensation (in shares)		1,000
Share-based compensation	293			292
Balance at end of period at Dec. 31, 2020	(20,892)	$ 37	0	81,840	(3,000)	(100,199)	430
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(5,668)					(5,668)
Shares issued on Credit Agreement	935	$ 8		927
Carrying amount of equity component	81			81
Other comprehensive income	(196)						(196)
Share-based compensation (in shares)		0
Share-based compensation	238			238
Balance at end of period at Dec. 31, 2021	(25,502)	$ 45	$ 0	$ 83,086	$ (3,000)	(105,633)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Deconsolidation of Subsidiaries, Amount	$ 0					$ 234	$ (234)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating Activities
Net loss	$ (5,668)	$ (12,730)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Income from discontinued operations, net of taxes	(165)	(238)
Depreciation and amortization	1,826	3,172
Share-based compensation expense	238	292
Gain on deconsolidation of subsidiaries	(5,659)	0
Impairment and amortization of intangible assets	1,252	390
Net realized losses	6,952	3
Amortization of financing costs	380	224
Forgiveness of Paycheck Protection Program loan	(6,601)	0
Net changes in operating assets and liabilities:
Premiums receivable, net	2,371	22,472
Other assets	841	(3,321)
Premiums payable	(5,823)	(24,572)
Due to deconsolidated affiliates	787	7,997
Other liabilities and accrued expenses	2,472	(2,959)
Net cash flows used in operating activities - continuing operations	(6,797)	(9,270)
Net cash flows used in operating activities - discontinued operations	(4,866)	(15,261)
Net cash flows used in operating activities	(11,663)	(24,531)
Purchases of:
Property, equipment and other	(4)	(200)
Proceeds from sale of:
Property, equipment and other	13	3
Net cash flows provided by (used in) investing activities - continuing operations	9	(197)
Net cash flows provided by investing activities - discontinued operations	3,342	10,578
Net cash flows provided by investing activities	3,351	10,381
Financing activities:
Proceeds from notes payable	2,500	4,601
Repayment of notes payable	(326)	(756)
Net cash flows provided by financing activities - continuing operations	2,174	3,845
Net cash flows provided by financing activities - discontinued operations	0	0
Net cash flows provided by financing activities	2,174	3,845
Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]
Net change in cash and cash equivalents	(4,614)	(5,622)
Cash and cash equivalents and restricted cash, beginning of period		13,554
Less: cash and cash equivalents of discontinued operations - beginning of period		3,029
Cash and cash equivalents, beginning of period	10,525	16,147
Cash and cash equivalents, end of period	5,911	10,525
Supplemental disclosure of cash information:
Cash paid for income taxes	0	(1,984)
Cash paid for interest	$ 828	$ 2,022

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Nature of Operations and Basis of Presentation	Nature of Operations and Basis of Presentation Atlas Financial Holdings, Inc. (“Atlas”, “We”, “us”, “our” or the “Company”) commenced operations on December 31, 2010. The primary business of Atlas focuses on a managing general agency (“MGA”) strategy, primarily through our wholly owned subsidiary, Anchor Group Management, Inc. (“AGMI”). AGMI focuses on a niche market orientation for the “light” commercial automobile sector. This sector includes taxi cabs, limousine, livery, full-time transportation network companies (“TNC”) drivers/operators, and other specialty commercial auto operators. Automobile insurance products provide insurance coverage in three major areas: liability, accident benefits and physical damage. Atlas’ business is carried out through its non-insurance company subsidiaries: AGMI, UBI Holdings Inc. (“UBI Holdings”) and UBI Holdings’ wholly-owned subsidiaries, optOn Digital IP Inc. (“OOIP”) and optOn Insurance Agency Inc. (“optOn” and together with OOIP and UBI Holdings, “UBI”). Prior to a strategic transition, our core business was the underwriting of commercial automobile insurance policies, focusing on the “light” commercial automobile sector, through American Country Insurance Company (“American Country”), American Service Insurance Company, Inc. (“American Service”) and Gateway Insurance Company (“Gateway” and together with American Country and American Service, the “ASI Pool Companies”) and Global Liberty Insurance Company of New York (“Global Liberty” and together with the ASI Pool Companies, our “Insurance Subsidiaries”), along with our wholly owned MGA, AGMI. The ASI Pool Companies were placed into rehabilitation under the statutory control of the Illinois Department of Insurance during the second half of 2019 and were subsequently placed into liquidation and have been deconsolidated from our consolidated financial statements as of October 1, 2019 as a result of these actions. Other regulatory actions were taken in certain states, including restriction, suspension, or revocation of certain state licenses and certificates of authority held by the ASI Pool Companies preceding and following the initiation of rehabilitation. During the fourth quarter of 2019, the Company began actively pursuing the potential sale of Global Liberty, and as a result, Global Liberty was held for sale and thus classified as a discontinued operation from October 1, 2019 through September 30, 2021. Global Liberty was placed into liquidation by the New York Department of Financial Services in October 2021 and, as a result, it has been deconsolidated from this report beginning October 2021. Atlas’ ordinary voting common shares are listed on the OTC Markets system under the symbol “AFHIQ”. Basis of Presentation These statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of Atlas and the entities it controls. Equity investments in entities that we do not consolidate, including corporate entities in which we have significant influence and partnership and partnership-like entities in which we have more than minor influence over operating and financial policies, are accounted for under the equity method unless we have elected the fair value option. All significant intercompany accounts and transactions have been eliminated. Seasonality Our insurance business is seasonal in nature. Our ability to generate commission income is also impacted by the timing of policy effective periods in the states in which we operate and products provided by our business partners. For example, January 1 st and March 1 st are common taxi cab renewal dates in Illinois and New York, respectively. Summary of Significant Accounting Policies Principles of Consolidation The consolidated financial statements include the accounts of Atlas and the entities it controls. Subsidiaries are entities over which Atlas, directly or indirectly, has the power to govern the financial and operating policies in order to obtain the benefits from their activities, generally accompanying an equity shareholding of more than one half of the voting rights. Subsidiaries are fully consolidated from the date on which control is transferred to Atlas and would be deconsolidated from the date that control ceases. The operating results of subsidiaries acquired or disposed of during the year will be included in the consolidated statements of operations from the effective date of acquisition and up to the effective date of disposal, as appropriate. All significant intercompany transactions and balances are eliminated in consolidation. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by Atlas. The following are Atlas’ subsidiaries, all of which are 100% owned, either directly or indirectly, together with the jurisdiction of incorporation, that are included in consolidated financial statements: • American Insurance Acquisition Inc. (Delaware) • Anchor Group Management Inc. (New York) • Anchor Holdings Group, Inc. (New York) • Global Liberty Insurance Company of New York (New York), classified as a discontinued operation through September 30, 2021 and then deconsolidated effective October 1, 2021 • UBI Holdings Inc. (Delaware) • optOn Digital IP Inc. (Delaware) • optOn Insurance Agency Inc. (Delaware) The following are Atlas’ subsidiaries, all of which Atlas retains the final equity claim against the estates, that are not included in consolidated financial statements, as management no longer has direct financial control over the estates of these entities: • The Estate of American Country Insurance Company (Illinois) • The Estate of American Service Insurance Company, Inc. (Illinois) • The Estate of Gateway Insurance Company (Illinois) • The Estate of Global Liberty (New York) Estimates and Assumptions The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates, and changes in estimates are recorded in the accounting period in which they are determined. Significant estimates in the accompanying financial statements include revenue recognition, evaluation of assets for impairment, valuation of financing instruments, and deferred tax asset valuation. Financial Instruments Financial instruments are recognized and unrecognized using trade date accounting, since that is the date Atlas contractually commits to the purchase or sale with the counter-party. Investment Income and Realized Gains (Losses) For securities other than mortgage-backed and asset-backed, Atlas utilizes the effective interest method to calculate the amortized cost of the financial asset and to amortize the premium or accrete the discount over the remaining life. The effective interest rate is the rate that discounts the estimated future cash flows through the expected life of the financial instrument. Mortgage-backed and asset-backed securities are valued using the retrospective adjustment method, which uses the effective interest method and includes anticipated prepayments. Interest income is reported net of amortization of premium and accretion of discount. Realized gains and losses on disposition of available-for-sale securities are based on the net proceeds and the adjusted cost of the securities sold using the specific identification method. Cash and Cash Equivalents Cash and cash equivalents include cash and highly liquid securities with original maturities of 90 days or less. Restricted Cash In its capacity as an MGA, AGMI collects premiums from agents and insureds and after deducting its commissions and/or fees, remits the premiums to the respective insurance underwriters according to the settlement terms of their respective managing general agency agreements. The collected but not remitted amounts are reported as restricted cash in the accompanying consolidated statements of financial position with the related liability reported as premiums payable. Premiums Receivable Premiums receivable include premium balances due and uncollected and installment premiums not yet due from agents and insureds. Atlas evaluates the collectability of accounts receivable based on a combination of factors. When aware of a specific customer’s inability to meet its financial obligations, such as in the case of bankruptcy or deterioration in the customer’s operating results or financial position, Atlas records a specific reserve for bad debt to reduce the related receivable to the amount Atlas reasonably believes is collectible. Atlas also records reserves for bad debt for all other customers based on a variety of factors, including the length of time the receivables are past due and historical collection experience. Accounts are reviewed for potential write-off on a case-by-case basis. Accounts deemed uncollectible are written off, net of expected recoveries. If circumstances related to specific customers change, estimates of the recoverability of receivables could be further adjusted. Income Taxes Income tax expense includes all taxes based on taxable income or loss of Atlas and its subsidiaries, and is recognized in the statements of operations except to the extent that they relate to items recognized directly in other comprehensive income, in which case the income tax effect is also recognized in other comprehensive income or loss. Deferred taxes are recognized based on the differences in the tax basis of assets, liabilities and items recognized directly in equity and the financial reporting basis of such items. Deferred tax assets are recognized only to the extent that it is probable that future taxable income will be available against which they can be utilized. Deferred tax assets and liabilities (“DTAs” and “DTLs”) are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on future tax assets and liabilities of a change in tax rates is recognized in income in the period of enactment. When considering the extent of the valuation allowance on Atlas’ DTAs, weight is given by management to both positive and negative evidence. U.S. GAAP states that a cumulative loss in recent years is a significant piece of negative evidence that is difficult to overcome in determining that a valuation allowance is not needed against DTAs. However, the strength and trend of earnings, as well as other relevant factors are considered. Atlas accounts for uncertain tax positions in accordance with the income taxes accounting guidance. Atlas analyzes filing positions in the federal and state jurisdiction where it is required to file tax returns, as well as the open tax years in these jurisdictions. Atlas would recognize interest and penalties related to unrecognized tax benefits as a component of the provision for federal income taxes. Intangible Assets Atlas recognized intangible assets as part of the acquisition of Anchor Holdings Group, Inc. The intangible assets are classified as either indefinite-lived or definite-lived depending on whether the useful lives can be identified. Atlas definite-lived intangible assets are amortized over their useful lives on a straight-line basis except for customer related intangibles, which are on an accelerated basis. Atlas definite-lived intangible assets consist of trade names and trademarks with useful lives of 15 years and customer relationships with useful lives of 10 years. The intangible assets are reviewed for impairment at least annually. Property and Equipment Buildings, office equipment and internal use software are stated at historical cost less depreciation and amortization. Subsequent costs are included in the asset’s carrying amount or capitalized as a separate asset only when it is probable that future economic benefits will be realized. Land is stated at historical cost. Internal use software includes costs associated with the Company’s policy and claims system including costs to develop those systems. Costs incurred during the preliminary project stage are expensed as incurred; costs incurred for activities during the application development stage are capitalized; and costs incurred during the post-implementation/operation stage are expensed as incurred. Upon reaching the post-implementation/operation stage of the development of internal use software, the capitalized costs are amortized over the estimated useful life of the asset. Depreciation on buildings and building improvements are provided on a straight-line basis over the estimated useful life of 33 years for buildings and 10 years for building improvements. Depreciation and amortization on equipment and internal use software is provided on a straight-line basis over the estimated useful lives which range from 5 years for vehicles, 5 years for furniture, 5 years for enterprise software and 3 years for all other software and computer equipment and the term of the lease for leased equipment. Repairs and maintenance are recognized as an expense during the period incurred. Revenue Recognition Revenues from contracts with customers include both commission and fee income. The recognition and measurement of revenue is based on the assessments of individual contract terms. As an MGA, AGMI has contracts with various insurance carrier partners to write premiums for specific programs which determines AGMI’s commission income revenue. Each contract specifies what our performance obligations are as an MGA and what determines our commission income revenue, generally gross written premiums, net of cancellations and refunds, times an MSA commission percentage. Under these contracts there are a number of performance obligations; however, it is the bundle of these services and not a single obligation that results in the performance of the MGA under the contracts. The Company considers these performance obligations as a non-bifurcated bundle of services where the performance obligations are satisfied simultaneous to the point in time where AGMI issues a policy, or cancels a policy to an insured. The commission rate stated in the individual contract is the standalone selling price of these non-bifurcated services which is allocated to the service bundle and not to any individual obligation under the various contracts. While Global Liberty remained consolidated in our financial statements, we recognized premium income on a pro rata basis over the terms of the respective insurance contracts. Share-Based Compensation Atlas has a share-based compensation plan that is described in Note 9, ‘Share-Based Compensation,’ to the Consolidated Financial Statements. Atlas uses the fair-value method of accounting to determine and account for equity settled transactions and to determine stock-based compensation for awards granted to employees and non-employees. Compensation expense is estimated based on the fair value of the award at the grant date and is recognized in net income over the requisite service period with a corresponding increase to additional paid in capital. The share-based compensation expense associated with awards that have graded vesting features and vest based on service conditions is calculated on a straight-line basis over the requisite service period for the entire award. Compensation expense recognized in connection with performance awards is based on the achievement of the specified performance and service conditions. During the recognition period compensation expense is accrued based on the performance condition that is probable of achievement. The final measure of compensation expense recognized over the requisite service period reflects the final performance outcome. Operating Segments Atlas operates in one business segment, the Managing General Agency segment. Convertible Senior Secured Delayed-Draw Credit Agreement The Company accounts for the issued Convertible Senior Secured Delayed-Draw Credit Agreement as separate liability and equity components. The carrying amount of the liability and equity components were calculated by utilizing the Black-Scholes modeling. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The Company has allocated issuance costs incurred to the liability and equity components. Issuance costs attributable to the liability component are being amortized to expense over the respective term of the Credit Agreement, and issuance costs attributable to the equity components were netted with the respective equity component in additional paid-in capital. To the extent that the Company receives conversion requests prior to the maturity of the Credit Agreement, a portion of the equity component is classified as temporary equity, which is measured as the difference between the principal and net carrying amount of the Credit Agreement requested for conversion. Upon settlement of the conversion requests, the difference between the fair value and the amortized book value of the liability component of the Notes requested for conversion is recorded as a gain or loss on early conversion. The fair value of the Credit Agreement is measured based on a similar liability that does not have an associated convertible feature based on the remaining term of the Credit Agreement, which requires significant judgment. Out-of-period Adjustment During the three months ended December 31, 2021, the Company recorded an out-of-period adjustment to correct premiums receivable and premiums payable related to the deconsolidation of the ASI Pool entities. The impact resulted in a $5.6 million gain on disposal of subsidiaries for the year ended December 31, 2021. Management concluded that the correction was not material to any current or previously issued consolidated financial statements. Reclassifications Certain accounts in the prior years’ consolidated financial statement have been reclassified for comparative purposes to conform to the current year’s presentation.

New Accounting Standards

New Accounting Standards	12 Months Ended
	Dec. 31, 2021
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Standards	New Accounting Standards Pertinent Accounting Standard Updates (“ASUs”) are issued from time to time by the FASB and are adopted by the Company as they become effective. All recently issued accounting pronouncements with effective dates prior to January 1, 2022 have been adopted by the Company. All other recently issued pronouncements with effective dates after December 31, 2021 are not expected to have a material impact on the consolidated financial statements.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Indefinite-lived intangible assets are tested for impairment annually or when a triggering event occurs. As a result of the liquidation and deconsolidation of Global Liberty, the Company recorded an impairment loss of $930,000 on intangible assets for the year ended December 31, 2021. There were no intangible asset impairments recorded for the year ended December 31, 2020. Intangible Assets by Major Asset Class ($ in ‘000s) Economic Useful Life Gross Carrying Amount Accumulated Amortization Accumulated Impairment Net As of December 31, 2021 Trade name and trademark 15 years $ 1,800 $ 817 $ — $ 983 Customer relationship 10 years 2,700 1,770 930 — $ 4,500 $ 2,587 $ 930 $ 983 As of December 31, 2020 Trade name and trademark 15 years $ 1,800 $ 703 $ — $ 1,097 Customer relationship 10 years 2,700 1,562 — 1,138 $ 4,500 $ 2,265 $ — $ 2,235 Atlas recognized amortization expense of $322,000 and $390,000 for the years ended December 31, 2021 and 2020, respectively. The following table presents the estimated future aggregate amortization expense for the years ending as follows: ($ in ‘000s) 2022 $ 120 2023 120 2024 120 2025 120 2026 120 Subsequent years 383 $ 983

Loss From Continuing Operations

Loss From Continuing Operations per Share	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Loss From Continuing Operations per Share	Loss From Continuing Operations per Share Computations of Basic and Diluted Loss per Common Share from Continuing Operations ($ in ‘000s, except share and per share amounts) Year ended December 31, 2021 2020 Basic Loss from continuing operations before income taxes $ (5,833) $ (13,452) Income tax expense (benefit) — (484) Net loss attributable to common shareholders from continuing operations $ (5,833) $ (12,968) Basic weighted average common shares outstanding 12,960,674 11,957,268 Loss per common share basic from continuing operations $ (0.45) $ (1.08) Diluted Basic weighted average common shares outstanding 12,960,674 11,957,268 Dilutive potential ordinary shares: Dilutive stock options outstanding — — Diluted weighted average common shares outstanding 12,960,674 11,957,268 Loss per common share diluted from continuing operations $ (0.45) $ (1.08) Common shares are defined as ordinary voting common shares, restricted voting common shares and participative RSUs. Earnings per common share diluted is computed by dividing net loss by the weighted average number of common shares outstanding for each period plus the incremental number of shares added as a result of converting dilutive potential ordinary voting common shares, calculated using the treasury stock method. Atlas’ potential dilutive ordinary voting common shares consists of outstanding stock options to purchase ordinary voting common shares and warrants to purchase 2,387,368 ordinary voting common shares of Atlas for $0.69 per share. The outstanding principal balance of the Convertible Senior Secured Delayed-Draw Credit Agreement can be converted at any time into ordinary voting common shares, at the applicable Lender’s discretion, at a rate of $0.35 per share, except that paid-in-kind interest included in the amount presented by a Lender for conversion may, at the Borrowers’ discretion, be paid in cash or converted into ordinary shares at the same rate. No such conversion has taken place.

Contracts with Customers

Contracts with Customers	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Contracts with Customers	Contracts with Customers The revenue included as commission income for 2021 and 2020 totaled $5.9 million and $5.2 million, respectively. The balance of receivables related to contracts with customers, which is recorded as part of premiums receivable on the Consolidated Statements of Financial Position as of December 31, 2021 and 2020: Components of Commission Receivables ($ in ‘000s) Year ended December 31, 2021 2020 Commission receivable, beginning of year $ 2,577 $ 1,428 Commission revenue 5,923 5,195 Net change in cash received (5,949) (4,046) Commission receivable, end of year $ 2,551 $ 2,577

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Reconciliation of U.S. Statutory Marginal Income Tax Rate to the Effective Tax Rate - Continuing Operations ($ in ‘000s) Year ended December 31, 2021 2020 Amount % Amount % Provision for taxes at U.S. statutory marginal income tax rate $ (1,225) 21.0 % $ (2,825) 21.0 % Provision for deferred tax assets deemed unrealizable (valuation allowance) 2,446 (41.9) 1,744 (13.0) Nondeductible expenses 3 (0.1) (3) — State tax (net of federal benefit) — — (3) — Stock compensation 7 (0.1) 630 (4.7) Gain from debt extinguishment (1,231) 21.1 — — Tax rate differential — — (42) 0.3 Other — — 15 (0.1) Provision for income taxes for continuing operations $ — — % $ (484) 3.5 % Reconciliation of U.S. Statutory Marginal Income Tax Rate to the Effective Tax Rate - Discontinued Operations ($ in ‘000s) Year ended December 31, 2021 2020 Amount % Amount % Provision for taxes at U.S. statutory marginal income tax rate $ 35 21.0 % $ (60) 21.0 % Provision for deferred tax assets deemed unrealizable (valuation allowance) (35) (21.0) (264) 92.9 Nondeductible expenses — — 2 (0.7) Tax rate differential — — (200) 70.4 Provision for income taxes for discontinued operations $ — — % $ (522) 183.6 % Components of Income Tax Benefit - Continuing Operations ($ in ‘000s) Year ended December 31, 2021 2020 Current tax benefit $ — $ (484) Components of Income Tax Benefit - Discontinued Operations ($ in ‘000s) Year ended December 31, 2021 2020 Current tax benefit $ — $ (522) During 2013 and 2019, due to shareholder activity, “triggering events” as determined under IRC Section 382 occurred. As a result, under IRC Section 382, the use of the Company’s net operating loss and other carryforwards generated prior to the “triggering events” will be subject to a yearly limitation as a result of this “ownership change” for tax purposes, which is defined as a cumulative change of more than 50% during any three-year period by shareholders owning 5% or greater portions of the Company’s shares. Due to the mechanics of the Section 382 calculation, when there are multiple triggering events the Company’s losses will generally be limited based on the thresholds of the 2019 triggering event. The Company has established a valuation allowance against the NOLs that will expire unused as a result of the yearly limitation. Components of Deferred Income Tax Assets and Liabilities ($ in ‘000s) December 31, 2021 2020 Gross deferred tax assets: Losses carried forward $ 6,657 $ 16,408 Claims liabilities and unearned premium reserves — 496 Investment in affiliates 28,250 23,870 Bad debts 47 168 Fixed assets 437 — Stock compensation 320 279 Other 670 203 Valuation allowance (35,894) (33,420) Total gross deferred tax assets 487 8,004 Gross deferred tax liabilities: Deferred policy acquisition costs — 134 Investments — 122 Fixed assets — 1,344 Intangible assets 206 469 Other 281 5,935 Total gross deferred tax liabilities 487 8,004 Net deferred tax assets $ — $ — Net Operating Loss Carryforward as of December 31, 2021 by Expiry Date ($ in ‘000s) Year of Occurrence Year of Expiration Amount 2011 2031 $ 1 2012 2032 70 2015 2035 1 2017 2037 12,085 2018 Indefinite 8,245 2019 Indefinite 5,241 2020 Indefinite 4,687 2021 Indefinite 1,372 Total $ 31,702 Deferred tax assets are recognized to the extent that it is probable that future taxable income will be available against which they can be utilized. When considering the extent of the valuation allowance on Atlas’ deferred tax assets, weight is given by management to both positive and negative evidence. U.S. GAAP states that a cumulative loss in recent years is a significant piece of negative evidence that is difficult to overcome in determining that a valuation allowance is not needed against deferred tax assets. Based on Atlas’ cumulative loss in recent years and certain deferred tax assets subject to a yearly limitation under Section 382 which will likely result in expiration before utilization, Atlas has established a valuation allowance of $35.9 million and $33.4 million for its gross future deferred tax assets as of December 31, 2021 and 2020, respectively. Atlas accounts for uncertain tax positions in accordance with the income taxes accounting guidance. Atlas has analyzed filing positions in the federal and state jurisdictions where it is required to file tax returns, as well as the open tax years in these jurisdictions. Atlas believes that its federal and state income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material change to its financial position. Therefore, no reserves for uncertain federal and state income tax positions have been recorded. Atlas would recognize interest and penalties related to unrecognized tax benefits as a component of the provision for federal income taxes. Atlas did not incur any federal income tax related interest income, interest expense or penalties in 2021 or 2020. Tax years 2015 and years thereafter are subject to examination by the Internal Revenue Service (“IRS”).

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies In the ordinary course of its business, Atlas is involved in legal proceedings, including lawsuits, regulatory examinations and inquiries. Atlas is exposed to credit risk on balances receivable from insureds and agents. Credit exposure to any one individual insured is not material. The policies placed with risk-taking partners are distributed by agents who may manage cash collection on its behalf pursuant to the terms of their agency agreement. Atlas has procedures to monitor and minimize its exposure to delinquent agent balances, including, but not limited to, reviewing agent account statements, processing policy cancellations for non-payment and other collection efforts deemed appropriate. As a managing agent, our ability to generate commission revenue is pursuant to contractual agreements with risk-taking partners. Our objective is to maintain long-term relationships with these risk-taking partners. Such relationships are dependent upon market conditions, business results, and other factors which may be outside of our control.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and Equipment Held 1 ($ in ‘000s) As of December 31, 2021 2020 Buildings 1 $ — $ 7,425 Land 1 — 1,840 Building improvements 1 — 9,031 Leasehold improvements 39 193 Internal use software 12,795 12,795 Computer equipment 1,842 1,838 Furniture and other office equipment 1,086 1,121 Total $ 15,762 $ 34,243 Accumulated depreciation (13,259) (15,428) Total property and equipment, net $ 2,503 $ 18,815 1 Held for sale. Depreciation expense and amortization from continuing operations was $1.8 million and $3.2 million in 2021 and 2020, respectively. During 2016, Atlas purchased a building and land for $9.3 million to serve as its new corporate headquarters to replace its former leased office space. Atlas’ Chicago area staff moved into this space in late October 2017 and occupies approximately 70,000 square feet in the building. An unrelated tenant occupies the remaining office space in the building, pursuant to a lease agreement with American Acquisition. Rental income related to this lease agreement was $477,000 and $462,000 in 2021 and 2020, respectively. Depreciation expense related to the building and its improvements was $284,000 and $1.1 million in 2021 and 2020, respectively. The decrease in depreciation expense for its corporate headquarters is a result of the held for sale status of the corporate headquarters. On April 1, 2021, the Company transitioned the assets related to its corporate headquarters from long-lived assets as held and used to long-lived assets held for sale. The Company has engaged an independent third party that is actively marketing the sale of the corporate headquarters including the land, building, building improvements and contents including furniture and fixtures. The Company engaged an independent third party that performed a valuation of the corporate headquarters and determined the fair market value as $7.5 million. The valuation of the corporate headquarters resulted in a net realized loss totaling $7.0 million for the year ended December 31, 2021. For the years ended December 31, 2021 and 2020, the Company capitalized $0 and $185,000, respectively, of costs incurred, consisting primarily of external consultants and internal labor costs incurred during the application development stage of the internal use software. Substantially all of the costs incurred during the period were part of the application development stage. For the years ended December 31, 2021 and 2020, there was $1.2 million and $1.4 million, respectively, of amortization expense recorded for projects in the post-implementation stage.

Share-Based Compensation

Share-Based Compensation	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Share Based Compensation	Share-Based Compensation On January 6, 2011, Atlas adopted a stock option plan (“Stock Option Plan”) in order to advance the interests of Atlas by providing incentives to eligible persons defined in the plan. In the second quarter of 2013, a new equity incentive plan (“Equity Incentive Plan”) was approved by the Company’s common shareholders at the Annual General Meeting, and Atlas ceased to grant new stock options under the preceding Stock Option Plan. The Equity Incentive Plan is a securities based compensation plan, pursuant to which Atlas may issue restricted stock grants for ordinary voting common shares, restricted stock, stock grants for ordinary voting common shares, stock options and other forms of equity incentives to eligible persons as part of their compensation. The Equity Incentive Plan is considered an amendment and restatement of the Stock Option Plan, although outstanding stock options issued pursuant to the Stock Option Plan will continue to be governed by the terms of the Stock Option Plan. Stock Options Stock Option Activity (prices in Canadian dollars designated with “C$” and U.S. dollars designated with “US$”) Year ended December 31, 2021 2020 Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price C$ Denominated: Outstanding, beginning of period — $ — 27,195 C$6.00 Granted — — — — Exercised — — — — Canceled — — (27,195) C$6.00 Outstanding, end of period — $ — — C$— US$ Denominated: Outstanding, beginning of period 181,500 US$13.51 375,000 US$17.01 Granted 1,016,000 US$0.49 — — Exercised — — — — Canceled — — (193,500) US$18.73 Outstanding, end of period 1,197,500 US$2.63 181,500 US$13.51 Options Outstanding As of December 31, 2021 Grant Date Expiration Date Number Outstanding Number Exercisable March 6, 2014 March 6, 2024 146,500 — March 12, 2015 March 12, 2025 35,000 — April 22, 2021 April 22, 2028 1,016,000 — Total 1,197,500 — There are no stock options that are exercisable as of December 31, 2021. The stock option grants outstanding have a weighted average remaining life of 5.72 years and have an intrinsic value of $0 as of December 31, 2021. On March 12, 2015, the Board of Directors of Atlas granted equity awards of (i) 200,000 restricted stock grants for ordinary voting common shares of the Company and (ii) 200,000 options to acquire ordinary voting common shares to the executive officers of the Company as part of the Company’s annual compensation process. The awards were made under the Company’s Equity Incentive Plan. The awards vest in five equal annual installments of 20%, provided that an installment shall not vest unless an annual performance target based on specific book value growth rates linked to return on equity goals is met. In the event the performance target is not met in any year, the 20% installment for such year shall not vest, but such non-vested installment shall carry forward and can become vested in future years (up to the fifth year from the date of grant), subject to achievement in a future year of the applicable performance target for such year. During 2020, 140,000 of the option awards were canceled as a result of not meeting the annual performance targets and an additional 53,500 options were canceled due to the departure of a former officer. During 2021 or 2020, no shares of either the restricted stock grants for ordinary voting common shares or the options to acquire ordinary voting common shares vested, due to not meeting annual performance targets. The Monte-Carlo simulation model was used, for both the options and restricted stock grants for ordinary voting common shares, to estimate the fair value of compensation expense as a result of the performance based component of these grants. Utilizing the Monte-Carlo simulation model, the fair values were $1.5 million and $1.9 million for the options and restricted stock grants for ordinary voting common shares, respectively. This expense was amortized over the anticipated vesting period. On April 22, 2021, the Company granted an aggregate of 1,016,000 options (“Options”) with an exercise price of $0.49 per common share of the Company to directors, managers, and executives pursuant to the Company’s Equity Incentive Plan. This exercise price is the average of the high bid and low asked prices on the date of the grant quoted on the OTC Bulletin Board Service. The Options granted to management will vest in three equal installments, with each installment vesting on the 1st, 2nd and 3rd anniversary of the date of the grant. The Options granted to independent directors vested immediately upon the date of the grant. The Options will expire on the seventh anniversary of the date of the grant. In the event of a change of control of the Company, or should a director’s or employee’s service with the Company be terminated other than for cause or voluntary resignation, any unvested Options will immediately vest. The estimated fair values of the Options are amortized to expense over the Options’ vesting period. The Company estimated the fair value of the Options at the date of the grant using the Black-Scholes option pricing model with the following weighted average assumptions: 2021 Expected risk-free interest rate 1.6 % Volatility 180.8 % Expected life (in years) 7.0 On December 31, 2018, the Company awarded restricted stock unit grants for ordinary voting common shares of the Company to its external directors pursuant to a director equity award agreement dated December 31, 2018. The awards, which were approved by the Company’s Board of Directors in March 2018, were valued at $40,000 per external director (“Aggregate Award”) and were made under the Company’s Equity Incentive Plan. The number of restricted stock units awarded was determined by dividing (A) the Aggregate Award by (B) the closing price of a Company ordinary voting common share at the close of market on April 4, 2018, which was $10.50 per share. For new directors, the Aggregate Award is proportionate to the director’s start date and priced as of that same day. During 2018, the Company awarded 17,524 RSU grants having an aggregate grant date fair value of $179,000. As of December 31, 2021, all of the RSU grants have vested. Restricted Shares Restricted Stock Grants for Ordinary Voting Common Shares and Restricted Share Unit Activity Year ended December 31, 2021 2020 Number of Shares Weighted Average Fair Value at Grant Date Number of Shares Weighted Average Fair Value at Grant Date Non-vested, beginning of period 3,301 $ 10.22 171,682 $ 17.46 Granted — — — — Vested (3,301) 0.12 (8,381) 10.22 Canceled — — (160,000) 9.62 Non-vested, end of period — $ — 3,301 $ 10.22 During 2020, 140,000 ordinary voting restricted common shares were canceled as a result of not meeting annual performance targets and an additional 20,000 restricted common shares were canceled due to the departure of a former officer. Also during 2020, 2,540 restricted share units vested related to the retirement of two former directors.

Other Employee Benefit Plans

Other Employee Benefit Plans	12 Months Ended
	Dec. 31, 2021
Other Employee Benefit Plans [Abstract]
Other Employee Benefit Plans	Other Employee Benefit Plans Defined Contribution Plan Atlas has a defined contribution 401(k) plan covering all qualified employees of Atlas and its subsidiaries. Contributions to this plan are limited based on IRS guidelines. Atlas matches 100% of the employee contribution up to 2.5% of annual earnings, plus 50% of additional contributions up to 2.5% of annual earnings, for a total maximum expense of 3.75% of annual earnings per participant. Atlas’ matching contributions are discretionary. Employees are 100% vested in their own contributions and vest in Atlas contributions based on years of service equally over 5 years with 100% vested after 5 years. Company contributions were $0 and $77,000 and in 2021 and 2020, respectively. The matching portion of this plan was suspended until further notice during the third quarter of 2020. Employee Stock Purchase Plan

Share Capital, Warrants and Mez

Share Capital, Warrants and Mezzanine Equity	12 Months Ended
	Dec. 31, 2021
Share Capital and Mezzanine Equity [Abstract]
Share Capital, Warrants and Mezzanine Equity	Share Capital, Warrants and Mezzanine Equity Share Capital Share Capital Activity As of December 31, 2021 2020 Shares Authorized 1 Shares Issued Shares Outstanding Amount ($ in ‘000s) Shares Issued Shares Outstanding Amount ($ in ‘000s) Ordinary voting common shares 800,000,001 15,052,839 14,797,334 $ 45 12,248,798 11,993,293 $ 37 Restricted voting common shares 33,333,334 — — — — — — Total common shares 833,333,335 15,052,839 14,797,334 $ 45 12,248,798 11,993,293 $ 37 1 Shares authorized increased from 266,666,667 to 800,000,001 effective July 12, 2021. There were 0 and 3,301 non-vested RSUs as of December 31, 2021 and 2020, respectively. These RSUs are participative and are included in the computations of earnings per common share and book value per common share for these periods. During 2021, the Company issued 2,804,041 ordinary voting common shares of which 2,750,000 ordinary voting common shares were issued in connection with the Credit Agreement, 50,740 ordinary voting common shares were issued under the near term incentive program, and 3,301 ordinary voting common shares were issued as a result of the vesting of RSUs. In March 2022, the Company issued an additional 2,500,000 voting common shares in connection with the Credit Agreement. During 2020, the Company issued 210,481 ordinary voting common shares of which 202,100 ordinary voting common shares were issued under the near term incentive program while 8,381 ordinary voting common shares were issued as a result of the vesting of RSUs. Also, during the year ended December 31, 2020, 140,000 ordinary voting restricted common shares were canceled due to not meeting performance targets, and 20,000 ordinary voting restricted common shares were canceled due to the departure of a former officer. Warrants The Schedule 13G/A filed by American Financial Group, Inc., a parent holding company, on January 20, 2022 states that as of December 31, 2021 it has sole voting power to vote 2,387,368 ordinary voting common shares and sole power to dispose of 2,387,368 ordinary voting common shares. These shares are represented by warrants to purchase 2,387,368 ordinary voting common shares until June 10, 2024, under a Warrant Agreement dated June 10, 2019 (the “Warrant Agreement”), at an initial exercise price of $0.69 per share, with both the number of ordinary voting common shares subject to the Warrant Agreement and the exercise price subject to adjustment as set forth in the Warrant Agreement. Atlas did not declare or pay any dividends to its common shareholders during 2021 or 2020. Convertible Senior Secured Delayed-Draw Credit Agreement The outstanding principal balance of the Term Loans can be converted at any time into ordinary voting common shares, at the applicable Lender’s discretion, at a rate of $0.35 per share, except that paid-in-kind interest included in the amount presented by a Lender for conversion may, at the Borrowers’ discretion, be paid in cash or converted into ordinary shares at the same rate. No such conversion has taken place. Mezzanine Equity

Leases

Leases	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Leases	Leases We currently lease real estate space and certain equipment under non-cancelable operating lease agreements. Leases with an initial term of 12 months or less, which are immaterial to the Company, are not recorded in the consolidated statement of financial position. The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized. The Company also elected the package of practical expedients permitted within the new standard, which among other things, allows the Company to carry forward historical lease classification. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases to lease payments based on changes in index rates or usage, are not recorded in the consolidated statements of financial position. Certain agreements include an option to extend or renew the lease term at our option. The operating lease liability includes lease payments related to options to extend or renew the lease term if the Company is reasonably certain of exercising those options. Lease payments are discounted using the implicit discount rate in the lease. If the implicit discount rate for the lease cannot be readily determined, the Company uses an estimate of its incremental borrowing rate. The Company did not have any contracts accounted for as finance leases as of December 31, 2021 or 2020. Lease Expense ($ in ‘000s) 2021 2020 Operating leases $ 676 $ 752 Variable lease cost 203 358 Total $ 879 $ 1,110 Other Operating Lease Information ($ in ‘000s) 2021 2020 Cash paid for amounts included in the measurement of lease liabilities reported in operating cash flows $ 714 $ 1,109 Right-of-use assets obtained in exchange for new lease liabilities — — Total $ 714 $ 1,109 The following table presents the undiscounted contractual maturities of the Company’s operating lease liability at December 31, 2021: Contractual Operating Lease Liabilities ($ in ‘000s) 2022 $ 179 2023 23 Total lease payments $ 202 Impact of discounting 22 Operating lease liability $ 224 Supplemental Balance Sheet Disclosures ($ in ‘000s) Lease Component Balance Sheet Classification As of December 31, 2021 Lease right-of-use asset Right-of-use asset $ 237 Weighted-average remaining lease term 0.5 years Weighted-average discount rate 4.1 %

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Related Party TransactionsA member of the Company’s board of directors is a member of the administrative agent for the Credit Agreement as discussed further in Note 14.

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Notes Payable	Notes Payable Senior Unsecured Notes On April 26, 2017, Atlas issued $25 million of five-year 6.625% senior unsecured notes and received net proceeds of approximately $23.9 million after deducting underwriting discounts and commissions and other estimated offering expenses. The Notes were issued under an indenture and supplemental indenture that contain covenants that, among other things, limit: (i) the ability of Atlas to merge or consolidate, or lease, sell, assign or transfer all or substantially all of its assets; (ii) the ability of Atlas to sell or otherwise dispose of the equity securities of certain of its subsidiaries; (iii) the ability of certain of Atlas’ subsidiaries to issue equity securities; (iv) the ability of Atlas to permit certain of its subsidiaries to merge or consolidate, or lease, sell, assign or transfer all or substantially all of their respective assets; and (v) the ability of Atlas and its subsidiaries to incur debt secured by equity securities of certain of its subsidiaries. Interest on the Notes is payable quarterly on each January 26, April 26, July 26 and October 26. Pursuant to the supplemental indenture, Atlas may, at its option, beginning with the interest payment date of April 26, 2020, and on any scheduled interest payment date thereafter, redeem the Notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest to, but excluding, the date of redemption. The Notes rank senior in right of payment to any of Atlas’ existing and future indebtedness that is by its terms expressly subordinated or junior in right of payment to the senior unsecured notes. The Notes rank equally in right of payment to all of Atlas’ existing and future senior indebtedness, but are effectively subordinated to any secured indebtedness to the extent of the value of the collateral securing such secured indebtedness. In addition, the Notes are structurally subordinated to the indebtedness and other obligations of Atlas’ subsidiaries. On August 31, 2021, the Company entered into the RSA with holders of approximately 48% of the aggregate principal amount of the Notes, and subsequently holder of approximately an additional 9.0% of the aggregate principal amount of the Notes acceded to the RSA for a total of approximately 57% (collectively, the “Supporting Noteholders”). Effective as of February 22, 2022 the Company entered into an amendment of the RSA with the requisite majority of Supporting Noteholders to extend the date by which the Note Restructuring must be competed (so-called the Scheme Longstop Date under the RSA) to April 15, 2022. The RSA memorializes the agreed-upon terms for the Note Restructuring. The RSA contemplates that the Note Restructuring will be effectuated through (i) the Scheme and (ii) a recognition proceeding with respect to the Scheme pursuant to chapter 15 of title 11 of the United States Code. Under the terms of the RSA, as amended, the Note Restructuring is expected to be completed by April 15, 2022, resulting in a five-year extension of the stated maturity through April 26, 2027 and other agreed modifications. The Company expects that the contemplated restructuring will enable it to satisfy its obligations under New Notes and create value for stakeholders. Each Supporting Noteholder has been fully supportive of the proposed Note Restructuring and has agreed, as reflected in the RSA, to, among other things, (i) work in good faith with the Company and its advisors to implement the Note Restructuring as soon as possible in a manner consistent with the terms of the RSA; (ii) support the Note Restructuring and vote and exercise any powers or rights available to it in favor of any matter requiring approval to the extent necessary to implement the Note Restructuring; (iii) not take, direct, encourage, assist or support (or procure that any other person takes, directs, encourages, assist or supports) any action which would, or would reasonably be expected to, breach or be inconsistent with the RSA or the Note Restructuring, or delay, impede, or prevent the implementation or consummation thereof; (iv) oppose any party or person from taking any Restricted Actions (as defined in the RSA); (v) negotiate in good faith and use commercially reasonable efforts to execute and implement the Definitive Restructuring Documents (as defined in and consistent with the RSA) to which it is required to be a party and coordinate its activities with the other parties (to the extent practicable and subject to the terms of the RSA) in respect of all matters concerning the implementation and consummation of the RSA; and (vi) cooperate with and assist the Company in obtaining additional support for the Note Restructuring from the Company’s stakeholders. The RSA allows other holders of the Notes to accede to the RSA and become Supporting Noteholders. On January 4, 2022, the Company initiated the Cayman Proceeding. Pursuant to the summons for directions, the Company sought the Convening Order for the convening of the Scheme Meeting. At the Scheme Meeting, holders of 91.83% of the Notes in number and 99.34% par amount of those voting voted in favor of the Scheme and, on February 25, 2022, the Cayman Court sanctioned and approved the Scheme by entry of the Sanction Order. In furtherance of the Cayman Proceeding and in connection with the Note Restructuring, on March 4, 2022, the Company filed the Recognition Petition, seeking that the Bankruptcy Court enter the Recognition and Enforcement Order. On March 4, 2022, the Bankruptcy Court entered an order, which, among other things, scheduled the Recognition Hearing. The Recognition Hearing was held on March 30, 2022, and, on the same day, the Bankruptcy Court entered the final and non-appealable Recognition and Enforcement Order, recognizing the Cayman Proceeding as the foreign main proceeding and enforcing the Scheme within the territorial jurisdiction of the United States, among other relief. Among other things, the Recognition and Enforcement Order provides that, pursuant to section 1145 of the Bankruptcy Code, once issued, the New Notes will be exempt from registration under Section 5 of the Securities Act, and any applicable state and local securities laws and freely transferable, subject to certain limitations under section 1145(b) of the Bankruptcy Code with respect to any New Notes issued to “underwriters” as defined in section 2(a)(11) of the Securities Act. The procurement of the Recognition and Enforcement Order was the last in-court step in the Note Restructuring. The Recognition and Enforcement Order is effective immediately and enforceable upon entry, authorizing the Company take any action to implement and effectuate the Note Restructuring, including finalization of ancillary documents, among other things, in an effort to proceed toward closing the Note Restructuring in accordance with the Scheme and the RSA. Pursuant to the terms of the Note Restructuring, the Notes will be canceled and the New Notes will be issued in exchange on or around April 15, 2022. The accrued but unpaid interest on the Notes as of the date the New Notes are issued will be capitalized and added onto the principal of the New Notes. The New Notes will be issued by the Company pursuant to a second supplemental indenture and will have a maturity date of April 27, 2027. The New Notes will be unsecured with an interest rate of 6.625% per annum, if paid in cash, and 7.25% per annum, if paid in kind, with a paid-in-kind option allowing the Company to pay interest in kind for up to two years from the date the New Notes are issued. Additionally, the Company will have the option to redeem the New Notes after three years at the principal amount to be redeemed as well as the option to redeem New Notes in an amount related to capitalized PIK interest on the New Notes, plus any accrued but unpaid interest, with no penalty. The Company intends to utilize the extended maturity of the New Notes to execute on its technology and analytics driven MGA strategy, with the objective of creating value for all stakeholders. The New Notes will to be issued in reliance on the exemption to registration provided by section 1145 of the Bankruptcy Code, except with respect to those New Notes issued to an “underwriter” as defined in section 2(a)(11) of the Securities Act under section 1145(b) of the Bankruptcy Code that will be subject to certain restrictions upon resale, and the authorization of the Bankruptcy Court pursuant to the Recognition and Enforcement Order; however, the Company intends to use its best efforts to seek registration of the New Notes following the Note Restructuring. Mortgage On November 10, 2016, American Acquisition entered into a ten-year 5.0% fixed rate mortgage agreement with the Insurance Subsidiaries totaling $10.7 million with principal and interest payments due monthly. The mortgage is secured by the Company’s headquarters and was previously eliminated in consolidation. The mortgage balances payable as of December 31, 2021 and 2020 were $8.0 million and $6.9 million, respectively. Paycheck Protection Program Loans On May 1, 2020, American Acquisition entered into a PPP Note with respect to a loan of $4,600,500 (the "First PPP Loan") from Fifth Third. The First PPP Loan was obtained pursuant to the Paycheck Protection Program of the CARES Act administered by the SBA. The First PPP Loan had a maturity date of May 1, 2022 and interest at a rate of 1.0% per annum. On June 14, 2021, American Acquisition received notification from the SBA that the First PPP Loan principal and related interest has been forgiven. On February 7, 2021, American Acquisition entered into the Second PPP Loan from Fifth Third. The Second PPP Loan was obtained pursuant to the SBA’s Paycheck Protection Program Second Draw Loans under the SB Act and is subject to the terms and conditions of the SB Act, the CARES Act and related legislation and regulations. The Company was eligible for the Second PPP Loan because its equity securities were not a National Markets System stock traded on a national securities exchange as defined by Section 6 of the Securities Exchange Act. The Second PPP Loan had a maturity date of February 7, 2026 and interest at a rate of 1.0% per annum. On December 10, 2021, American Acquisition received notification from the SBA that the Second PPP Loan principal and related interest has been forgiven. Credit Agreement On September 1, 2021, the Company and certain Borrowers, entered into the Credit Agreement, with the Agent and the Lenders, pursuant to which the Lenders made available to the Borrowers an aggregate principal amount of up to $3,000,000 Term Loans. The Credit Agreement provides for an initial advance of $2 million in Term Loans and up to $1 million of additional Delayed Draws within 18 months of closing, in each case, subject to the satisfaction of waiver of certain funding conditions and the other terms and conditions set forth in the Credit Agreement. The Borrowers may use the proceeds of the Term Loans for payments of certain agreed upon permitted expenditures, which include expenses expected to be incurred in connection with the Note Restructuring. Interest will accrue on the funded Term Loans at 12% per annum and may be paid, at the Borrowers’ option, in cash or in kind; provided, that upon the occurrence and during the continuance of an event of default, the interest rate will be increased to 14% per annum and will be payable only in cash. The term of the term loan facility is 24 months. In October 2021, and January 2022, the Lenders advanced an aggregate of $2 million of the Term Loans and, in March 2022, the Lenders advanced $1 million of delayed draws under the Term Loans, in each case despite the fact that not all of the funding conditions had been met. As a set-up fee for the term loan facility, 2,750,000 ordinary voting common shares of the Company were issued to the Lenders upon execution of the agreement, and an additional 2,500,000 ordinary voting common shares were issued to the Lenders in March 2022, in connection with the Delayed Draws. The outstanding principal balance of the Term Loans can be converted at any time into ordinary voting common shares, at the applicable Lender’s discretion, at a rate of $0.35 per share, except that paid-in-kind interest included in the amount presented by a Lender for conversion may, at the Borrowers’ discretion, be paid in cash or converted into ordinary shares at the same rate. Under the Credit Agreement, the Borrowers have the option at any time to prepay the Term Loans in whole or in part subject to the payment of certain yield protection obligations. The Lenders have the right to demand prepayment, along with payment of certain yield protection obligations, upon the occurrence of an event of default, change of control, sale of certain assets of the Borrowers, a casualty event, eminent domain, or condemnation, in each case, subject to negotiated limitations. The Credit Agreement requires the satisfaction or waiver of certain funding conditions and that the Borrower comply with customary affirmative and negative covenants, including covenants governing and restricting indebtedness, liens, investments, sales of assets, distributions, and fundamental changes in the Borrowers’ organizational structure and line of business and maintaining certain levels of liquidity. The obligation of the Lenders to make any of the Term Loans is conditioned upon the grant to the Agent, on behalf of the Lenders, of a first priority perfected security interest in collateral consisting of substantially all of the assets of the Borrowers to secure the payment in full of the Term Loans and all other obligations under the Credit Agreement and related loan documentation. The collateral will include pledges of the equity of the Company’s direct and indirect subsidiaries American Acquisition, AGMI, Anchor Holdings Group, Inc., and UBI. Upon payment in full of the Term Loans, the Company will have no further obligations to the Agent and the Lenders under the Credit Agreement and other related loan documentation other than the obligation to register the ordinary shares issued pursuant to the Credit Agreement, and the security interests granted by the Borrowers in favor of the Agent, on behalf of the Lenders, will terminate. For year end 2021, Management engaged an independent third-party valuation firm which determined the fair value of the Credit Agreement conversion option using Black-Scholes modeling. The fair value of the liability portion was determined to be $367,000 and was deducted from the $500,000 initial draw amount. The balance, or $133,000, was allocated to equity. The equity component of the Credit Agreement will not be remeasured as long as it continues to meet the conditions for equity classification. The Company recorded a non-cash set-up fee related to the Credit Agreement totaling $935,000, which was the fair value of the shares issued for the Credit Agreement. As a result of not drawing against the Credit Agreement during Q3 2021, this non-cash set-up fee was recorded as an asset in the Company’s consolidated statements of financial position during Q3 2021 and was being amortized on a straight-line basis over the contractual term of the access period. On October 2, 2021, an initial $500,000 was drawn against the Credit Agreement, and, as a result a portion of the non-cash set-up fee, or $165,000, was reclassified from the asset to a liability as debt discount and $59,000 of the non-cash set-up fee was allocated to equity. The debt discount and the amount allocated to equity are amortized to interest expense over the term of the Credit Agreement using the straight line method. Liability and Equity Components of Credit Agreement ($ in ‘000s) As of December 31, 2021 Liability component: Principal amount $ 367 Unamortized debt discount (143) Net carrying amount $ 224 Carrying amount of equity component $ 81 During the first quarter of 2022, the Lenders advanced the remaining $1.5 million and $1.0 million of additional draw amounts. Interest Expense Interest expense on notes payable was $2.2 million and $2.3 million in 2021 and 2020, respectively. Notes Payable Outstanding ($ in ‘000s) As of December 31, 2021 2020 6.625% Senior Unsecured Notes due April 26, 2022 $ 25,000 $ 25,000 1.0% PPP Loan due May 1, 2022 — 4,601 12.0% Credit Agreement, net of discount, due August 31, 2023 224 — 5.0% Mortgage due November 10, 2026 7,950 6,863 Total outstanding borrowings 33,174 36,464 Unamortized issuance costs (72) (296) Total notes payable $ 33,102 $ 36,168

Deconsolidation and Discontinue

Deconsolidation and Discontinued Operations	12 Months Ended
	Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]
Deconsolidation and Discontinued Operations	Deconsolidation and Discontinued Operations Deconsolidation As part of the deconsolidation of the ASI Pool Companies during 2019, notes receivable from the estates of the ASI Pool Companies with outstanding principal and accrued interest balances of $18.0 million are now presented on the Consolidated Statements of Financial Position. On May 1, 2015, American Acquisition entered into subordinated surplus debentures (“Surplus Notes”) with the ASI Pool Companies that had a maturity date of April 30, 2020 carrying a variable interest equal to the corporate base rate as reported by the largest bank (measured in assets) with its head office located in Chicago, Illinois, in effect on the first business day of each month for the term of the Surplus Notes plus two percent per annum on the unpaid principal balance with a maximum variable interest rate for any month not to exceed the initial rate for the Surplus Notes by more than ten percent per annum. These Surplus Notes are subject to various terms and conditions as set forth by the Illinois Department of Insurance and require prior written approval for the payment of interest and/or the reduction in principal. These Surplus Notes could be used at some point to offset future amounts payable related to income tax settlements and various other intercompany settlements to the estates of the ASI Pool Companies. Effective October 1, 2021, Atlas no longer has statutory responsibility or authority over the financial activities of Global Liberty while still maintaining their indirect ownership of Global Liberty. The Company recognized a gain of $126,000 relating to the deconsolidation for the year ended December 31, 2021. The financial results of Global Liberty are included in the consolidated statements of operations as a discontinued operation through the October 1, 2021 disposal date. There was no re-measurement of any retained interest since no future value was assigned to Global Liberty as a result of the liquidation. Discontinued Operations During the fourth quarter of 2019, the Company began actively pursuing the potential sale of Global Liberty, and as a result, Global Liberty was held for sale and thus classified as a discontinued operation until October 2021 and the results of Global Liberty’s operations are reported separately for all periods presented. Global Liberty was not sold within the one year guidance as set forth by ASC 205-20-45-1E(d) to continue classifying Global Liberty as a discontinued operation. However, due to the confluence of events and circumstances beyond the Company’s control, ASC 205-20-45-1G(c) provides for an exception to the one year guidance which the Company believes fits its situation. As a result of the Company applying the exception guidance, Global Liberty remained as a discontinued operation through September 30, 2021. Global Liberty was placed into liquidation by the New York Department of Financial Services in October 2021 and, as a result, it has been deconsolidated from this reporting beginning October 2021. Summary financial information for Global Liberty included in income from discontinued operations, net of tax in the consolidated statements of operations for the years ended December 31, 2021 and 2020 is presented below: Income From Discontinued Operations ($ in ‘000s) Period through Year ended September 30, December 31, 2021 2020 Net premiums earned $ 7,765 $ 13,908 Net investment loss (106) (102) Net realized gains (losses) 155 (1,411) Other income 7 — Total revenue 7,821 12,395 Net claims incurred 5,980 689 Acquisition costs (280) 6,875 Other underwriting expenses 1,956 5,117 Interest income — (2) Total expenses 7,656 12,679 Income (loss) from operations before income taxes 165 (284) Income tax benefit — (522) Net income $ 165 $ 238 Statements of Comprehensive Income (Loss) Net income $ 165 $ 238 Other comprehensive (loss) income: Changes in net unrealized investment gains (21) 161 Reclassification to net (loss) (175) (155) Other comprehensive (loss) income (196) 6 Total comprehensive (loss) income $ (31) $ 244 The assets and liabilities of Global Liberty are presented as held for sale in the consolidated statements of financial position at December 31, 2020, however, due to the deconsolidation as of October 1, 2021, Global Liberty’s assets and liabilities will no longer be included in the consolidated financial statements: ($ in ‘000s) December 31, 2020 Assets Investments Fixed income securities, available for sale, at fair value (amortized cost $0 and $4,315) $ 4,544 Other investments 1,319 Total investments 5,863 Cash and cash equivalents 3,029 Accrued investment income 29 Reinsurance recoverables on amounts paid 581 Reinsurance recoverables on amounts unpaid 31,958 Prepaid reinsurance premiums 9,739 Deferred policy acquisition costs 637 Other assets 2,049 Total assets $ 53,885 Liabilities Claims liabilities $ 38,499 Unearned premium reserves 14,545 Due to reinsurers 10 Other liabilities and accrued expenses 7,353 Total liabilities $ 60,407

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Going Concern Under Accounting Standards Codification (“ASC”) 205-40 Going Concern, we have the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet our future financial obligations as they become due within one year after the date that the consolidated financial statements are issued. As required by this standard, our evaluation shall initially not take into consideration the potential mitigating effects of our plans that have not been fully implemented as of the date the consolidated financial statements are issued. In complying with the requirements under ASC 205-40 to complete an evaluation without considering mitigating factors, the Company considered several conditions or events including (1) uncertainty around the continued impact of the COVID-19 pandemic on the Company’s operations and consolidated financial results, (2) the $25 million of the Notes maturing on April 26, 2022, (3) recurring operating losses for fiscal periods through December 31, 2021, (4) the Company’s negative equity, and (5) the Company’s working capital limitations. The above conditions raise substantial doubt about the Company’s ability to continue as a going concern for the 12-month period following the date the fiscal year 2021 consolidated financial statements are issued. In performing the second step of this assessment, we are required to evaluate whether our plans to mitigate the conditions above alleviate the substantial doubt about our ability to meet our obligations as they become due within one year after the date that the consolidated financial statements are issued. Our future plans may potentially include, without limitation, one or more of the following: (1) securing incremental capital with the objective of potentially repurchasing some or all of the Senior Unsecured Notes at a discount to par, in the open market or otherwise, (2) securing equity or debt capital in private or public transactions, or (3) offering to exchange some or all of the Senior Unsecured Notes for debt, equity and/or other securities or other consideration, through privately negotiated transactions or otherwise. The constraints and requirements related to the Company’s current senior notes coupled with market conditions could create limitations with respect to such alternatives. Management believes that the Company’s capital requirements will depend on many factors including the success of the Company’s business development efforts. Management also believes the Company may need to raise additional capital for working capital purposes There is no assurance that such financing will be available in the future. The conditions described above raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. There is no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds will be available through external sources. The lack of additional capital resulting from the inability to generate cash flow from operations or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material effect on the business. Furthermore, there can be no assurance that any such required funds, if available, will be available on attractive terms or they will not have a significant dilutive effect on the Company’s existing shareholders. In the absence of the successful execution of one or more of the Company’s previously mentioned mitigating actions, we have therefore concluded there is substantial doubt about our ability to continue as a going concern through or beyond March 2023. The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from our failure to continue as a going concern. For more information on the Senior Unsecured Notes, see Note 14 and for more information relating to recent developments regarding the restructuring of the Senior Unsecured Notes, see Note 17.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On January 4, 2022, the Company filed a petition and summons for direction in the Cayman Court regarding the Scheme proposed by the Company related to the Note Restructuring. Pursuant to the summons for directions, the Company sought the Convening Order for the convening of the Scheme Meeting. At the Scheme Meeting, holders of 91.83% of the Notes in number and 99.34% par amount of those voting voted in favor of the Scheme and, on February 25, 2022, the Cayman Court sanctioned and approved the Scheme by entry of the Sanction Order. Effective as of February 28, 2022, the Company entered into an amendment of the RSA with the requisite majority of Supporting Noteholders to extend the date by which the Note Restructuring must be completed (so-called the Scheme Longstop Date under the RSA) to April 15, 2022. In furtherance of the Cayman Proceeding and in connection with the Note Restructuring, on March 4, 2022, the Company filed the Recognition Petition, seeking that the Bankruptcy Court enter the Recognition and Enforcement Order. On March 4, 2022, the Bankruptcy Court entered an order, which, among other things, scheduled the Recognition Hearing. The Recognition Hearing was held on March 30, 2022, and, on the same day, the Bankruptcy Court entered the final and non-appealable Recognition and Enforcement Order, recognizing the Cayman Proceeding as the foreign main proceeding and enforcing the Scheme within the territorial jurisdiction of the United States, among other relief. Among other things, the Recognition and Enforcement Order provides that, pursuant to section 1145 of the Bankruptcy Code, once issued, the New Notes will be exempt from registration under Section 5 of the Securities Act, and any applicable state and local securities laws and freely transferable, subject to certain limitations under section 1145(b) of the Bankruptcy Code with respect to any New Notes issued to “underwriters” as defined in section 2(a)(11) of the Securities Act. The procurement of the Recognition and Enforcement Order was the last in-court step in the Note Restructuring. The Recognition and Enforcement Order is effective immediately and enforceable upon entry, authorizing the Company to take any action to implement and effectuate the Note Restructuring, including finalization of ancillary documents, among other things, in an effort to proceed toward closing the Note Restructuring in accordance with the Scheme and the RSA. For more information on the Note Restructuring and the RSA, see Note 14. On March 25, 2022, the Company amended the Credit Agreement with the Lenders to increase the number of ordinary common shares the Company would be required to issue in connection with a Delayed Draw and the Lenders subsequently advanced $1 million of Delayed Draws under the Term Loans. For more information on the Credit Agreement and the Term Loans, see Note 14. On March 30, 2022, the Compensation Committee of the Board of Directors of the Company approved the 2022 compensation for its directors, officers and senior managers. For more information, see “Part II, Item 9B, Other Information”.

Nature of Operations and Basi_2

Nature of Operations and Basis of Presentation Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation
Principles of consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Atlas and the entities it controls. Subsidiaries are entities over which Atlas, directly or indirectly, has the power to govern the financial and operating policies in order to obtain the benefits from their activities, generally accompanying an equity shareholding of more than one half of the voting rights. Subsidiaries are fully consolidated from the date on which control is transferred to Atlas and would be deconsolidated from the date that control ceases. The operating results of subsidiaries acquired or disposed of during the year will be included in the consolidated statements of operations from the effective date of acquisition and up to the effective date of disposal, as appropriate. All significant intercompany transactions and balances are eliminated in consolidation. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by Atlas. The following are Atlas’ subsidiaries, all of which are 100% owned, either directly or indirectly, together with the jurisdiction of incorporation, that are included in consolidated financial statements: • American Insurance Acquisition Inc. (Delaware) • Anchor Group Management Inc. (New York) • Anchor Holdings Group, Inc. (New York) • Global Liberty Insurance Company of New York (New York), classified as a discontinued operation through September 30, 2021 and then deconsolidated effective October 1, 2021 • UBI Holdings Inc. (Delaware) • optOn Digital IP Inc. (Delaware) • optOn Insurance Agency Inc. (Delaware) The following are Atlas’ subsidiaries, all of which Atlas retains the final equity claim against the estates, that are not included in consolidated financial statements, as management no longer has direct financial control over the estates of these entities: • The Estate of American Country Insurance Company (Illinois) • The Estate of American Service Insurance Company, Inc. (Illinois) • The Estate of Gateway Insurance Company (Illinois) • The Estate of Global Liberty (New York)
Estimates and assumptions	Estimates and Assumptions The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates, and changes in estimates are recorded in the accounting period in which they are determined. Significant estimates in the accompanying financial statements include revenue recognition, evaluation of assets for impairment, valuation of financing instruments, and deferred tax asset valuation.
Investments	Investment Income and Realized Gains (Losses) For securities other than mortgage-backed and asset-backed, Atlas utilizes the effective interest method to calculate the amortized cost of the financial asset and to amortize the premium or accrete the discount over the remaining life. The effective interest rate is the rate that discounts the estimated future cash flows through the expected life of the financial instrument. Mortgage-backed and asset-backed securities are valued using the retrospective adjustment method, which uses the effective interest method and includes anticipated prepayments. Interest income is reported net of amortization of premium and accretion of discount. Realized gains and losses on disposition of available-for-sale securities are based on the net proceeds and the adjusted cost of the securities sold using the specific identification method.
Cash, and cash equivalents, and short-term investments	Cash and Cash Equivalents Cash and cash equivalents include cash and highly liquid securities with original maturities of 90 days or less.
Cash and cash equivalents, restricted cash	Cash and Cash Equivalents Cash and cash equivalents include cash and highly liquid securities with original maturities of 90 days or less. Restricted Cash
Premiums receivable	Premiums Receivable Premiums receivable include premium balances due and uncollected and installment premiums not yet due from agents and insureds.
Income taxes	Income Taxes Income tax expense includes all taxes based on taxable income or loss of Atlas and its subsidiaries, and is recognized in the statements of operations except to the extent that they relate to items recognized directly in other comprehensive income, in which case the income tax effect is also recognized in other comprehensive income or loss. Deferred taxes are recognized based on the differences in the tax basis of assets, liabilities and items recognized directly in equity and the financial reporting basis of such items. Deferred tax assets are recognized only to the extent that it is probable that future taxable income will be available against which they can be utilized. Deferred tax assets and liabilities (“DTAs” and “DTLs”) are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on future tax assets and liabilities of a change in tax rates is recognized in income in the period of enactment. When considering the extent of the valuation allowance on Atlas’ DTAs, weight is given by management to both positive and negative evidence. U.S. GAAP states that a cumulative loss in recent years is a significant piece of negative evidence that is difficult to overcome in determining that a valuation allowance is not needed against DTAs. However, the strength and trend of earnings, as well as other relevant factors are considered. Atlas accounts for uncertain tax positions in accordance with the income taxes accounting guidance. Atlas analyzes filing positions in the federal and state jurisdiction where it is required to file tax returns, as well as the open tax years in these jurisdictions. Atlas would recognize interest and penalties related to unrecognized tax benefits as a component of the provision for federal income taxes.
Intangible assets	Intangible Assets Atlas recognized intangible assets as part of the acquisition of Anchor Holdings Group, Inc. The intangible assets are classified as either indefinite-lived or definite-lived depending on whether the useful lives can be identified. Atlas definite-lived intangible assets are amortized over their useful lives on a straight-line basis except for customer related intangibles, which are on an accelerated basis. Atlas definite-lived intangible assets consist of trade names and trademarks with useful lives of 15 years and customer relationships with useful lives of 10 years. The intangible assets are reviewed for impairment at least annually.
Property and equipment	Property and Equipment Buildings, office equipment and internal use software are stated at historical cost less depreciation and amortization. Subsequent costs are included in the asset’s carrying amount or capitalized as a separate asset only when it is probable that future economic benefits will be realized. Land is stated at historical cost. Internal use software includes costs associated with the Company’s policy and claims system including costs to develop those systems. Costs incurred during the preliminary project stage are expensed as incurred; costs incurred for activities during the application development stage are capitalized; and costs incurred during the post-implementation/operation stage are expensed as incurred. Upon reaching the post-implementation/operation stage of the development of internal use software, the capitalized costs are amortized over the estimated useful life of the asset. Depreciation on buildings and building improvements are provided on a straight-line basis over the estimated useful life of 33 years for buildings and 10 years for building improvements. Depreciation and amortization on equipment and internal use software is provided on a straight-line basis over the estimated useful lives which range from 5 years for vehicles, 5 years for furniture, 5 years for enterprise software and 3 years for all other software and computer equipment and the term of the lease for leased equipment.
Revenue recognition	Revenue Recognition Revenues from contracts with customers include both commission and fee income. The recognition and measurement of revenue is based on the assessments of individual contract terms. As an MGA, AGMI has contracts with various insurance carrier partners to write premiums for specific programs which determines AGMI’s commission income revenue. Each contract specifies what our performance obligations are as an MGA and what determines our commission income revenue, generally gross written premiums, net of cancellations and refunds, times an MSA commission percentage. Under these contracts there are a number of performance obligations; however, it is the bundle of these services and not a single obligation that results in the performance of the MGA under the contracts. The Company considers these performance obligations as a non-bifurcated bundle of services where the performance obligations are satisfied simultaneous to the point in time where AGMI issues a policy, or cancels a policy to an insured. The commission rate stated in the individual contract is the standalone selling price of these non-bifurcated services which is allocated to the service bundle and not to any individual obligation under the various contracts.
Share-based payments	Share-Based Compensation Atlas
Operating segments	Operating Segments
Reclassifications	Reclassifications Certain accounts in the prior years’ consolidated financial statement have been reclassified for comparative purposes to conform to the current year’s presentation.
New accounting standards	All recently issued accounting pronouncements with effective dates prior to January 1, 2022 have been adopted by the Company. All other recently issued pronouncements with effective dates after December 31, 2021 are not expected to have a material impact on the consolidated financial statements.

Intangible Assets Intangible As

Intangible Assets Intangible Assets by Major Asset Class (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Intangible Assets by Major Asset Class ($ in ‘000s) Economic Useful Life Gross Carrying Amount Accumulated Amortization Accumulated Impairment Net As of December 31, 2021 Trade name and trademark 15 years $ 1,800 $ 817 $ — $ 983 Customer relationship 10 years 2,700 1,770 930 — $ 4,500 $ 2,587 $ 930 $ 983 As of December 31, 2020 Trade name and trademark 15 years $ 1,800 $ 703 $ — $ 1,097 Customer relationship 10 years 2,700 1,562 — 1,138 $ 4,500 $ 2,265 $ — $ 2,235
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The following table presents the estimated future aggregate amortization expense for the years ending as follows: ($ in ‘000s) 2022 $ 120 2023 120 2024 120 2025 120 2026 120 Subsequent years 383 $ 983

Loss From Continuing Operatio_2

Loss From Continuing Operations per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Schedule of Earnings Per Common Shares, Basic and Diluted	Computations of Basic and Diluted Loss per Common Share from Continuing Operations ($ in ‘000s, except share and per share amounts) Year ended December 31, 2021 2020 Basic Loss from continuing operations before income taxes $ (5,833) $ (13,452) Income tax expense (benefit) — (484) Net loss attributable to common shareholders from continuing operations $ (5,833) $ (12,968) Basic weighted average common shares outstanding 12,960,674 11,957,268 Loss per common share basic from continuing operations $ (0.45) $ (1.08) Diluted Basic weighted average common shares outstanding 12,960,674 11,957,268 Dilutive potential ordinary shares: Dilutive stock options outstanding — — Diluted weighted average common shares outstanding 12,960,674 11,957,268 Loss per common share diluted from continuing operations $ (0.45) $ (1.08)

Contracts with Customers (Table

Contracts with Customers (Tables)	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Contract with Customer, Contract Asset, Contract Liability, and Receivable	The balance of receivables related to contracts with customers, which is recorded as part of premiums receivable on the Consolidated Statements of Financial Position as of December 31, 2021 and 2020: Components of Commission Receivables ($ in ‘000s) Year ended December 31, 2021 2020 Commission receivable, beginning of year $ 2,577 $ 1,428 Commission revenue 5,923 5,195 Net change in cash received (5,949) (4,046) Commission receivable, end of year $ 2,551 $ 2,577

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation	Reconciliation of U.S. Statutory Marginal Income Tax Rate to the Effective Tax Rate - Continuing Operations ($ in ‘000s) Year ended December 31, 2021 2020 Amount % Amount % Provision for taxes at U.S. statutory marginal income tax rate $ (1,225) 21.0 % $ (2,825) 21.0 % Provision for deferred tax assets deemed unrealizable (valuation allowance) 2,446 (41.9) 1,744 (13.0) Nondeductible expenses 3 (0.1) (3) — State tax (net of federal benefit) — — (3) — Stock compensation 7 (0.1) 630 (4.7) Gain from debt extinguishment (1,231) 21.1 — — Tax rate differential — — (42) 0.3 Other — — 15 (0.1) Provision for income taxes for continuing operations $ — — % $ (484) 3.5 % Reconciliation of U.S. Statutory Marginal Income Tax Rate to the Effective Tax Rate - Discontinued Operations ($ in ‘000s) Year ended December 31, 2021 2020 Amount % Amount % Provision for taxes at U.S. statutory marginal income tax rate $ 35 21.0 % $ (60) 21.0 % Provision for deferred tax assets deemed unrealizable (valuation allowance) (35) (21.0) (264) 92.9 Nondeductible expenses — — 2 (0.7) Tax rate differential — — (200) 70.4 Provision for income taxes for discontinued operations $ — — % $ (522) 183.6 %
Schedule of Components of Income Tax Expense (Benefit)	Components of Income Tax Benefit - Continuing Operations ($ in ‘000s) Year ended December 31, 2021 2020 Current tax benefit $ — $ (484) Components of Income Tax Benefit - Discontinued Operations ($ in ‘000s) Year ended December 31, 2021 2020 Current tax benefit $ — $ (522)
Schedule of Deferred Tax Assets and Liabilities	Components of Deferred Income Tax Assets and Liabilities ($ in ‘000s) December 31, 2021 2020 Gross deferred tax assets: Losses carried forward $ 6,657 $ 16,408 Claims liabilities and unearned premium reserves — 496 Investment in affiliates 28,250 23,870 Bad debts 47 168 Fixed assets 437 — Stock compensation 320 279 Other 670 203 Valuation allowance (35,894) (33,420) Total gross deferred tax assets 487 8,004 Gross deferred tax liabilities: Deferred policy acquisition costs — 134 Investments — 122 Fixed assets — 1,344 Intangible assets 206 469 Other 281 5,935 Total gross deferred tax liabilities 487 8,004 Net deferred tax assets $ — $ —
Summary of Operating Loss Carryforwards	Net Operating Loss Carryforward as of December 31, 2021 by Expiry Date ($ in ‘000s) Year of Occurrence Year of Expiration Amount 2011 2031 $ 1 2012 2032 70 2015 2035 1 2017 2037 12,085 2018 Indefinite 8,245 2019 Indefinite 5,241 2020 Indefinite 4,687 2021 Indefinite 1,372 Total $ 31,702

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and Equipment Held 1 ($ in ‘000s) As of December 31, 2021 2020 Buildings 1 $ — $ 7,425 Land 1 — 1,840 Building improvements 1 — 9,031 Leasehold improvements 39 193 Internal use software 12,795 12,795 Computer equipment 1,842 1,838 Furniture and other office equipment 1,086 1,121 Total $ 15,762 $ 34,243 Accumulated depreciation (13,259) (15,428) Total property and equipment, net $ 2,503 $ 18,815 1 Held for sale.

Share Based Compensation (Table

Share Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	Stock Option Activity (prices in Canadian dollars designated with “C$” and U.S. dollars designated with “US$”) Year ended December 31, 2021 2020 Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price C$ Denominated: Outstanding, beginning of period — $ — 27,195 C$6.00 Granted — — — — Exercised — — — — Canceled — — (27,195) C$6.00 Outstanding, end of period — $ — — C$— US$ Denominated: Outstanding, beginning of period 181,500 US$13.51 375,000 US$17.01 Granted 1,016,000 US$0.49 — — Exercised — — — — Canceled — — (193,500) US$18.73 Outstanding, end of period 1,197,500 US$2.63 181,500 US$13.51
Schedule of Option Outstanding	Options Outstanding As of December 31, 2021 Grant Date Expiration Date Number Outstanding Number Exercisable March 6, 2014 March 6, 2024 146,500 — March 12, 2015 March 12, 2025 35,000 — April 22, 2021 April 22, 2028 1,016,000 — Total 1,197,500 —
Schedule of Restricted Stock and Restricted Stock Units Activity	Restricted Stock Grants for Ordinary Voting Common Shares and Restricted Share Unit Activity Year ended December 31, 2021 2020 Number of Shares Weighted Average Fair Value at Grant Date Number of Shares Weighted Average Fair Value at Grant Date Non-vested, beginning of period 3,301 $ 10.22 171,682 $ 17.46 Granted — — — — Vested (3,301) 0.12 (8,381) 10.22 Canceled — — (160,000) 9.62 Non-vested, end of period — $ — 3,301 $ 10.22
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The Company estimated the fair value of the Options at the date of the grant using the Black-Scholes option pricing model with the following weighted average assumptions: 2021 Expected risk-free interest rate 1.6 % Volatility 180.8 % Expected life (in years) 7.0

Share Capital and Mezzanine Equ

Share Capital and Mezzanine Equity (Tables)	12 Months Ended
	Dec. 31, 2021
Share Capital and Mezzanine Equity [Abstract]
Schedule of Stock by Class	Share Capital Activity As of December 31, 2021 2020 Shares Authorized 1 Shares Issued Shares Outstanding Amount ($ in ‘000s) Shares Issued Shares Outstanding Amount ($ in ‘000s) Ordinary voting common shares 800,000,001 15,052,839 14,797,334 $ 45 12,248,798 11,993,293 $ 37 Restricted voting common shares 33,333,334 — — — — — — Total common shares 833,333,335 15,052,839 14,797,334 $ 45 12,248,798 11,993,293 $ 37 1 Shares authorized increased from 266,666,667 to 800,000,001 effective July 12, 2021.

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Lease, Cost	Lease Expense ($ in ‘000s) 2021 2020 Operating leases $ 676 $ 752 Variable lease cost 203 358 Total $ 879 $ 1,110 Other Operating Lease Information ($ in ‘000s) 2021 2020 Cash paid for amounts included in the measurement of lease liabilities reported in operating cash flows $ 714 $ 1,109 Right-of-use assets obtained in exchange for new lease liabilities — — Total $ 714 $ 1,109
Lessee, Operating Lease, Liability, Maturity	The following table presents the undiscounted contractual maturities of the Company’s operating lease liability at December 31, 2021: Contractual Operating Lease Liabilities ($ in ‘000s) 2022 $ 179 2023 23 Total lease payments $ 202 Impact of discounting 22 Operating lease liability $ 224 Supplemental Balance Sheet Disclosures ($ in ‘000s) Lease Component Balance Sheet Classification As of December 31, 2021 Lease right-of-use asset Right-of-use asset $ 237 Weighted-average remaining lease term 0.5 years Weighted-average discount rate 4.1 %

Notes Payable (Tables)

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of Debt, Liability and Equity Components of Credit Agreement	Liability and Equity Components of Credit Agreement ($ in ‘000s) As of December 31, 2021 Liability component: Principal amount $ 367 Unamortized debt discount (143) Net carrying amount $ 224 Carrying amount of equity component $ 81
Summary of Outstanding Debt	Notes Payable Outstanding ($ in ‘000s) As of December 31, 2021 2020 6.625% Senior Unsecured Notes due April 26, 2022 $ 25,000 $ 25,000 1.0% PPP Loan due May 1, 2022 — 4,601 12.0% Credit Agreement, net of discount, due August 31, 2023 224 — 5.0% Mortgage due November 10, 2026 7,950 6,863 Total outstanding borrowings 33,174 36,464 Unamortized issuance costs (72) (296) Total notes payable $ 33,102 $ 36,168

Deconsolidation and Discontin_2

Deconsolidation and Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	Summary financial information for Global Liberty included in income from discontinued operations, net of tax in the consolidated statements of operations for the years ended December 31, 2021 and 2020 is presented below: Income From Discontinued Operations ($ in ‘000s) Period through Year ended September 30, December 31, 2021 2020 Net premiums earned $ 7,765 $ 13,908 Net investment loss (106) (102) Net realized gains (losses) 155 (1,411) Other income 7 — Total revenue 7,821 12,395 Net claims incurred 5,980 689 Acquisition costs (280) 6,875 Other underwriting expenses 1,956 5,117 Interest income — (2) Total expenses 7,656 12,679 Income (loss) from operations before income taxes 165 (284) Income tax benefit — (522) Net income $ 165 $ 238 Statements of Comprehensive Income (Loss) Net income $ 165 $ 238 Other comprehensive (loss) income: Changes in net unrealized investment gains (21) 161 Reclassification to net (loss) (175) (155) Other comprehensive (loss) income (196) 6 Total comprehensive (loss) income $ (31) $ 244 The assets and liabilities of Global Liberty are presented as held for sale in the consolidated statements of financial position at December 31, 2020, however, due to the deconsolidation as of October 1, 2021, Global Liberty’s assets and liabilities will no longer be included in the consolidated financial statements: ($ in ‘000s) December 31, 2020 Assets Investments Fixed income securities, available for sale, at fair value (amortized cost $0 and $4,315) $ 4,544 Other investments 1,319 Total investments 5,863 Cash and cash equivalents 3,029 Accrued investment income 29 Reinsurance recoverables on amounts paid 581 Reinsurance recoverables on amounts unpaid 31,958 Prepaid reinsurance premiums 9,739 Deferred policy acquisition costs 637 Other assets 2,049 Total assets $ 53,885 Liabilities Claims liabilities $ 38,499 Unearned premium reserves 14,545 Due to reinsurers 10 Other liabilities and accrued expenses 7,353 Total liabilities $ 60,407

Nature of Operations and Basi_3

Nature of Operations and Basis of Presentation Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)
Accounting Policies [Abstract]
Gain on disposal of subsidiaries	$ 5.6

Nature of Operations and Basi_4

Nature of Operations and Basis of Presentation Intangible Assets (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Trade name and trademark
Finite-Lived Intangible Assets [Line Items]
Economic Useful Life	15 years	15 years
Customer relationship
Finite-Lived Intangible Assets [Line Items]
Economic Useful Life	10 years	10 years

Nature of Operations and Basi_5

Nature of Operations and Basis of Presentation Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2021
Building and Building Improvements
Property, Plant and Equipment [Line Items]
Useful lives	33 years
Building improvements1
Property, Plant and Equipment [Line Items]
Useful lives	10 years
Vehicles
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Furniture
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Enterprise Software
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Software and Development Costs
Property, Plant and Equipment [Line Items]
Useful lives	3 years
Computer Equipment
Property, Plant and Equipment [Line Items]
Useful lives	3 years

Nature of Operations and Basi_6

Nature of Operations and Basis of Presentation Operating Segments (Details)	12 Months Ended
	Dec. 31, 2021segment
Accounting Policies [Abstract]
Number of operating segments (segment)	1

Intangible Assets - Intangible

Intangible Assets - Intangible Assets by Major Asset Class (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 4,500	$ 4,500
Accumulated Amortization	2,587	2,265
Accumulated Impairment	930	0
Net	$ 983	$ 2,235
Trade name and trademark
Finite-Lived Intangible Assets [Line Items]
Economic Useful Life	15 years	15 years
Gross Carrying Amount	$ 1,800	$ 1,800
Accumulated Amortization	817	703
Accumulated Impairment	0	0
Net	$ 983	$ 1,097
Customer relationship
Finite-Lived Intangible Assets [Line Items]
Economic Useful Life	10 years	10 years
Gross Carrying Amount	$ 2,700	$ 2,700
Accumulated Amortization	1,770	1,562
Accumulated Impairment	930	0
Net	$ 0	$ 1,138

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Accumulated impairment	$ 930,000	$ 0
Amortization of intangible assets	$ 322,000	$ 390,000

Intangible Assets - Future Amor

Intangible Assets - Future Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
2022	$ 120
2023	120
2024	120
2025	120
2026	120
Subsequent years	383
Net	$ 983	$ 2,235

Loss From Continuing Operatio_3

Loss From Continuing Operations per Share Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Basic:
Loss from continuing operations before income taxes	$ (5,833)	$ (13,452)
Income tax expense (benefit)	0	(484)
Net loss attributable to common shareholders from continuing operations	$ (5,833)	$ (12,968)
Basic weighted average common shares outstanding (in shares)	12,960,674	11,957,268
Earnings (loss) per common share basic from continuing operations (in dollars per share)	$ (0.45)	$ (1.08)
Diluted:
Dilutive stock options outstanding (in shares)	0	0
Diluted weighted average common shares outstanding (in shares)	12,960,674	11,957,268
Earnings (loss) per common share diluted from continuing operations (in dollars per share)	$ (0.45)	$ (1.08)

Loss From Continuing Operatio_4

Loss From Continuing Operations per Share (Details) - $ / shares	Dec. 31, 2021	Sep. 01, 2021	Jun. 10, 2019
Potential Dilutive Securities from Earnings Per Share [Line Items]
Exercise price of warrants or rights (in US dollars per share)	$ 0.69		$ 0.69
Conversion rate per share (in dollars per share)		$ 0.35
Ordinary Voting Common Shares, Warrants to Purchase
Potential Dilutive Securities from Earnings Per Share [Line Items]
Class of warrant or right, outstanding (in shares)	2,387,368		2,387,368

Contracts with Customers (Detai

Contracts with Customers (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Commission revenue	$ 5,923	$ 5,195

Contracts with Customers - Comm

Contracts with Customers - Commissions Revenue Roll Forward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Commissions Receivable [Roll Forward]
Commission receivable, beginning of year	$ 2,577	$ 1,428
Commission revenue	5,923	5,195
Net change in cash received	(5,949)	(4,046)
Commission receivable, end of year	$ 2,551	$ 2,577

Income Taxes - Income Tax Rate

Income Taxes - Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Provision for taxes at U.S. statutory marginal income tax rate	$ (1,225)	$ (2,825)
Provision for deferred tax assets deemed unrealizable (valuation allowance)	2,446	1,744
Nondeductible expenses	3	(3)
State tax (net of federal benefit)	0	(3)
Stock compensation	7	630
Gain from debt extinguishment	(1,231)	0
Tax rate differential	0	(42)
Other	0	15
Provision for income taxes for continuing operations	$ 0	$ (484)
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Provision for taxes at U.S. statutory marginal income tax rate, percent	21.00%	21.00%
Provision for deferred tax assets deemed unrealizable (valuation allowance), percent	(41.90%)	(13.00%)
Nondeductible expenses, percent	(0.10%)	0.00%
State tax (net of federal benefit), percent	0.00%	0.00%
Stock compensation, percent	(0.10%)	(4.70%)
Nondeductible goodwill, percent	0.211	0
Tax rate differential, percent	0.00%	0.30%
Other, percent	0.00%	(0.10%)
Effective income tax rate	0.00%	3.50%
Discontinued Operations
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Provision for taxes at U.S. statutory marginal income tax rate	$ 35	$ (60)
Provision for deferred tax assets deemed unrealizable (valuation allowance)	(35)	(264)
Nondeductible expenses	0	2
Tax rate differential	0	(200)
Provision for income taxes for continuing operations	$ 0	$ (522)
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Provision for taxes at U.S. statutory marginal income tax rate, percent	21.00%	21.00%
Provision for deferred tax assets deemed unrealizable (valuation allowance), percent	(21.00%)	92.90%
Nondeductible expenses, percent	0.00%	(0.70%)
Tax rate differential, percent	0.00%	70.40%
Effective income tax rate	0.00%	183.60%

Income Taxes - Components of In

Income Taxes - Components of Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Tax Contingency [Line Items]
Current tax benefit	$ 0	$ (484)
Discontinued Operations
Income Tax Contingency [Line Items]
Current tax benefit	$ 0	$ (522)

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Gross deferred tax assets:
Losses carried forward	$ 6,657	$ 16,408
Claims liabilities and unearned premium reserves	0	496
Investment in affiliates	28,250	23,870
Bad debts	47	168
Fixed assets	437	0
Stock compensation	320	279
Other	670	203
Valuation allowance	(35,894)	(33,420)
Total gross deferred tax assets	487	8,004
Gross deferred tax liabilities:
Deferred policy acquisition costs	0	134
Investments	0	122
Fixed assets	0	1,344
Intangible assets	206	469
Other	281	5,935
Total gross deferred tax liabilities	487	8,004
Net deferred tax assets	$ 0	$ 0

Income Taxes - Schedule of Tax

Income Taxes - Schedule of Tax Carryforwards (Details) $ in Thousands	Dec. 31, 2021USD ($)
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	$ 31,702
Carryforward Expiring in 2031
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	1
Carryforward Expiring in 2032
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	70
Carryforward Expiring in 2035
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	1
Carryforward Expiring in 2037
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	12,085
Carryforward Expiring Indefinite Originated In 2018
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	8,245
Carryforward Expiring Indefinite Originated In 2019
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	5,241
Carryforward Expiring Indefinite Originated In 2020
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	4,687
Carryforward Expiring Indefinite Originated In 2021
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, subject to expiration	$ 1,372

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Valuation allowance	$ 35,894	$ 33,420

Property and Equipment (Details

Property and Equipment (Details) ft² in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2016USD ($)	Oct. 01, 2017ft²
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 15,762	$ 34,243
Accumulated depreciation	(13,259)	(15,428)
Total property and equipment, net	2,503	18,815
Depreciation and amortization	1,826	3,172
Occupied area of corporate headquarters building | ft²				70,000
Rental income	477	462
Fair market value	7,500
Net realized loss	7,000
Capitalized costs	0	185
Amortization of capitalized costs	1,200	1,400
Net realized losses	(6,952)	(3)
Building and land
Property, Plant and Equipment [Line Items]
Property and land addition			$ 9,300
Buildings1
Property, Plant and Equipment [Line Items]
Property and equipment, gross	0	7,425
Land1
Property, Plant and Equipment [Line Items]
Property and equipment, gross	0	1,840
Building improvements1
Property, Plant and Equipment [Line Items]
Property and equipment, gross	0	9,031
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	39	193
Internal use software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	12,795	12,795
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,842	1,838
Furniture and other office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,086	1,121
Building and Building Improvements
Property, Plant and Equipment [Line Items]
Depreciation and amortization	284	1,100
Equipment
Property, Plant and Equipment [Line Items]
Net realized losses	0	(3)
Continuing Operations
Property, Plant and Equipment [Line Items]
Depreciation and amortization	$ 1,800	$ 3,200

Share-Based Compensation Schedu

Share-Based Compensation Schedule of Activity Related Share-Based Compensation (Details)	Apr. 22, 2021$ / shares	Dec. 31, 2021$ / sharesshares	Dec. 31, 2021$ / sharesshares	Dec. 31, 2020$ / sharesshares	Dec. 31, 2020$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options, outstanding (in shares), end of period | shares		1,197,500	1,197,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Granted in period (in US or Canadian dollars per share) | $ / shares	$ 0.49
CANADA
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options, outstanding (in shares), beginning of period | shares		0	0	27,195	27,195
Options, granted in period (in shares) | shares		0	0	0	0
Options, exercised in period (in shares) | shares		0	0	0	0
Options, canceled in period (in shares) | shares		0	0	(27,195)	(27,195)
Options, outstanding (in shares), end of period | shares		0	0	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, outstanding, weighted average exercise price, beginning balance (in Canadian or US dollars per share) | $ / shares		$ 0		$ 6
Granted in period (in US or Canadian dollars per share) | $ / shares		0		0
Options, exercised in period, weighted average exercise price (in Canadian or US dollars per share) | $ / shares		0		0
Options, canceled in period, weighted average exercise price (in Canadian or US dollars per share) | $ / shares		0		6
Options, outstanding, weighted average exercise price, end of period (in Canadian or US dollars per share) | $ / shares		$ 0		$ 0
UNITED STATES
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options, outstanding (in shares), beginning of period | shares		181,500	181,500	375,000	375,000
Options, granted in period (in shares) | shares		1,016,000	1,016,000	0	0
Options, exercised in period (in shares) | shares		0	0	0	0
Options, canceled in period (in shares) | shares		0	0	(193,500)	(193,500)
Options, outstanding (in shares), end of period | shares		1,197,500	1,197,500	181,500	181,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, outstanding, weighted average exercise price, beginning balance (in Canadian or US dollars per share) | $ / shares			$ 13.51		$ 17.01
Granted in period (in US or Canadian dollars per share) | $ / shares			0.49		0
Options, exercised in period, weighted average exercise price (in Canadian or US dollars per share) | $ / shares			0		0
Options, canceled in period, weighted average exercise price (in Canadian or US dollars per share) | $ / shares			0		18.73
Options, outstanding, weighted average exercise price, end of period (in Canadian or US dollars per share) | $ / shares			$ 2.63		$ 13.51

Share-Based Compensation Sche_2

Share-Based Compensation Schedule of Outstanding Options (Details)	Dec. 31, 2021shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, outstanding (in shares)	1,197,500
Options, exercisable (in shares)	0
March 6, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, outstanding (in shares)	146,500
Options, exercisable (in shares)	0
March 12, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, outstanding (in shares)	35,000
Options, exercisable (in shares)	0
April 22, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, outstanding (in shares)	1,016,000
Options, exercisable (in shares)	0

Share-Based Compensation Stock

Share-Based Compensation Stock Options - Additional Information (Details)	Apr. 22, 2021segment$ / sharesshares	Mar. 31, 2018USD ($)	Mar. 12, 2015installmentshares	Dec. 31, 2021USD ($)shares	Dec. 31, 2020USD ($)shares	Dec. 31, 2018USD ($)shares	Apr. 04, 2018$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, exercisable (in shares)				0
Grants, weighted average remaining life				5 years 8 months 19 days
Options, outstanding, intrinsic value | $				$ 0
Restricted shares canceled during period (in shares)					140,000
Options granted (in shares)	1,016,000
Exercise price (in dollars per share) | $ / shares	$ 0.49
Share-based compensation expense | $					$ 292,000
March 12, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, exercisable (in shares)				0
April 22, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, exercisable (in shares)				0
Restricted Stock Grants | March 12, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted share awards, nonvested, fair value | $				$ 1,900,000
Stock Options | March 12, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, nonvested, fair value | $				$ 1,500,000
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares vested during period (in shares)					2,540
Restricted share and restricted share units grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares canceled during period (in shares)					140,000
Restricted stock and restricted stock units (RSUs) Grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares granted during period (in shares)				0	0
Restricted shares vested during period (in shares)				3,301	8,381
Restricted shares canceled during period (in shares)				0	160,000
Share-based compensation expense | $				$ 238,000
Unearned share-based compensation expense | $				$ 0
Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares canceled during period (in shares)					53,500
Officer | March 12, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage			20.00%
Award vesting period | installment			5
Officer | April 22, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period | segment	3
Officer | Restricted Stock Grants | March 12, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares granted during period (in shares)			200,000
Restricted shares vested during period (in shares)					0
Officer | Stock Options | March 12, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, granted in period (in shares)			200,000
Officer | Restricted share and restricted share units grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares canceled during period (in shares)					20,000
Equity Incentive Plan | December 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price (in US dollars per share) | $ / shares							$ 10.50
Equity Incentive Plan | Director | Restricted Stock Units (RSUs) | December 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of shares issued | $		$ 40,000
Restricted shares granted during period (in shares)						17,524
Aggregate grant date fair value | $						$ 179,000

Share-Based Compensation - Valu

Share-Based Compensation - Valuation Assumptions (Details)	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Expected risk-free interest rate	1.60%
Volatility	180.80%
Expected life (in years)	7 years

Share-Based Compensation Sche_3

Share-Based Compensation Schedule of Restricted Shares and Restricted Share Units (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense		$ 292
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted shares nonvested at period start (in shares)	3,301
Restricted shares vested during period (in shares)		(2,540)
Restricted shares nonvested at period end (in shares)	0	3,301
Restricted stock and restricted stock units (RSUs) Grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 238
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted shares nonvested at period start (in shares)	3,301	171,682
Restricted shares granted during period (in shares)	0	0
Restricted shares vested during period (in shares)	(3,301)	(8,381)
Restricted shares canceled during period (in shares)	0	(160,000)
Restricted shares nonvested at period end (in shares)	0	3,301
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average fair value at grant date, restricted shares nonvested at period start (in US dollars per share)	$ 10.22	$ 17.46
Weighted average fair value at grant date, restricted shares granted during period (in US dollars per share)	0	0
Weighted average fair value at grant date, restricted shares vested during period (in US dollars per share)	0.12	10.22
Weighted average fair value at grant date, restricted shares canceled during period (in US dollars per share)	0	9.62
Weighted average fair value at grant date, restricted shares nonvested at period end (in US dollars per share)	$ 0	$ 10.22

Other Employee Benefit Plans De

Other Employee Benefit Plans Defined Contribution Plan (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Other Employee Benefit Plans [Abstract]
Defined contribution plan, percent of employee contribution matched by employer, up to 2.5% annual earnings	100.00%
Defined contribution plan, percent of employees annual earnings employer will match 100%	2.50%
Defined contribution plan, percent of employer match on additional employee contributions, up to 2.5% annual earnings	50.00%
Defined contribution plan, percent of additional employees annual earnings employer will match 50%	2.50%
Defined contribution plan, employer matching contribution, maximum percent of employees' gross pay	3.75%
Defined contribution plan, employee contribution vesting percentage	100.00%
Defined contribution plan, employers matching contribution, vesting period	5 years
Defined contribution plan, company contributions	$ 0	$ 77

Other Employee Benefit Plans Em

Other Employee Benefit Plans Employee Stock Purchase Plan (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)
Other Employee Benefit Plans [Abstract]
Employee stock purchase plan, hours per week threshold to be eligible	30 hours
Employee stock purchase plan, maximum annual contribution percent of annual earnings per employee	0.075
Employee stock purchase plan, percent of employee contribution matched by employer, up to 2.5% annual earnings	1
Employee stock purchase plan, percent of employees annual earnings employer will match 100%	2.50%
Employee stock purchase plan, percent of employer match on additional employee contributions, up to 5% annual earnings	50.00%
Employee stock purchase plan, percent of additional employees annual earnings employer will match 50%	5.00%
Employee stock purchase plan, employer matching contribution, maximum percent of employee's gross pay	5.00%
Employee stock purchase plan, company cost	$ 0	$ 21

Share Capital, Warrants and M_2

Share Capital, Warrants and Mezzanine Equity - Schedule of Stock by Class (Details) - USD ($) $ in Thousands	Mar. 30, 2022	Dec. 31, 2021	Jul. 12, 2021	Jul. 11, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Common shares, shares authorized (in shares)		833,333,335
Common shares, shares issued (in shares)		15,052,839			12,248,798
Common stock, shares, outstanding (in shares)	17,297,334	14,797,334			11,993,293
Common stock, value, outstanding (in US dollars)		$ 45			$ 37
Ordinary voting common shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)		800,000,001	800,000,001	266,666,667	800,000,001
Common shares, shares issued (in shares)		15,052,839			12,248,798
Common stock, shares, outstanding (in shares)		14,797,334			11,993,293
Common stock, value, outstanding (in US dollars)		$ 45			$ 37
Restricted voting common shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)		33,333,334			33,333,334
Common shares, shares issued (in shares)		0			0
Common stock, shares, outstanding (in shares)		0			0
Common stock, value, outstanding (in US dollars)		$ 0			$ 0

Share Capital, Warrants and M_3

Share Capital, Warrants and Mezzanine Equity Stock Activity and Mezzanine Equity - Narrative (Details) - $ / shares	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jun. 10, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ordinary voting common shares issued, restricted stock and RSU vesting (in shares)		2,804,041
Exercise price of warrants or rights (in US dollars per share)		$ 0.69		$ 0.69
Preferred shares, shares outstanding (in shares)		0	0
Ordinary voting common shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ordinary voting common shares issued, restricted stock and RSU vesting (in shares)			210,481
Incentive Program | Ordinary voting common shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ordinary voting common shares issued, restricted stock and RSU vesting (in shares)		50,740
Credit Facility Agreement | Ordinary voting common shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ordinary voting common shares issued, restricted stock and RSU vesting (in shares)		2,750,000
Credit Facility Agreement | Ordinary voting common shares | Subsequent Event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ordinary voting common shares issued, restricted stock and RSU vesting (in shares)	2,500,000
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested restricted stock units (RSUs) (in shares)		0	3,301
Ordinary voting common shares issued, restricted stock and RSU vesting (in shares)		3,301	8,381
Restricted Stock Units (RSUs) | Incentive Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ordinary voting common shares issued, restricted stock and RSU vesting (in shares)			202,100
Restricted share and restricted share units grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares canceled during period (in shares)			140,000
Restricted share and restricted share units grants | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares canceled during period (in shares)			20,000
Ordinary Voting Common Shares, Sole Power to Vote
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Class of warrant or right, outstanding (in shares)		2,387,368
Ordinary Voting Common Shares, Sole Power to Dispose of
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Class of warrant or right, outstanding (in shares)		2,387,368
Ordinary Voting Common Shares, Warrants to Purchase
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Class of warrant or right, outstanding (in shares)		2,387,368		2,387,368

Leases - Lease Expenses (Detail

Leases - Lease Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating leases	$ 676	$ 752
Variable lease cost	203	358
Total	$ 879	$ 1,110

Leases - Other Operating Lease

Leases - Other Operating Lease Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Cash paid for amounts included in the measurement of lease liabilities reported in operating cash flows	$ 714	$ 1,109
Right-of-use assets obtained in exchange for new lease liabilities	0	0
Total	$ 714	$ 1,109

Leases - Contractual Operating

Leases - Contractual Operating Lease Liability (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
2022	$ 179
2023	23
Total lease payments	202
Impact of discounting	22
Operating lease liability	224	$ 1,091
Right-of-use asset	$ 237	$ 888
Weighted-average remaining lease term	6 months
Weighted-average discount rate	4.10%

Notes Payable - Narrative (Deta

Notes Payable - Narrative (Details)

Sep. 01, 2021USD ($)$ / sharesshares

Aug. 31, 2021

Apr. 26, 2017USD ($)

Nov. 10, 2016USD ($)

Mar. 31, 2021USD ($)

Dec. 31, 2021USD ($)

Dec. 31, 2020USD ($)

Apr. 26, 2022

Mar. 31, 2022USD ($)

Jan. 31, 2022USD ($)

Jan. 04, 2022

Oct. 31, 2021USD ($)

Oct. 02, 2021USD ($)

Feb. 07, 2021

May 01, 2020USD ($)

Line of Credit Facility [Line Items]

Percent of debt held in agreement before additional holders

0.48

Additional percentage of holders participating in agreement

0.090

Percentage of holders participating in agreement

0.57

Extension period

5 years

Own-share lending arrangement, shares issued (in shares) | shares

2,750,000

Own-share lending arrangement, collateral shares, issued (in shares) | shares

2,500,000

Conversion rate per share (in dollars per share) | $ / shares

$ 0.35

Non-cash set-up fee, reclass to liability

$ 165,000

Non-cash set-up fee, reclass to equity

59,000

Notes payable, outstanding gross of unamortized issuance costs

$ 33,174,000

$ 36,464,000

Subsequent Event

Line of Credit Facility [Line Items]

Portion of debt used for restructuring activities

0.9183

Portion of debt used for restructuring activities, par amount

0.9934

Interest rate if paid in cash

0.06625

Interest rate if paid in kind

0.0725

PPP Loan

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 4,600,500

Debt instrument, interest rate, stated percentage

1.00%

Second Paycheck Protection Plan

Line of Credit Facility [Line Items]

Debt instrument, interest rate, stated percentage

1.00%

Loan Agreement | American Insurance Acquisition

Line of Credit Facility [Line Items]

Interest expense, including non-utilization fees

$ 2,200,000

2,300,000

Loan Agreement | 5.0% Mortgage due November 10, 2026 | American Insurance Acquisition

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 10,700,000

Debt instrument, interest rate, stated percentage

5.00%

5.00%

Notes payable, outstanding gross of unamortized issuance costs

$ 7,950,000

6,863,000

Credit Agreement

Line of Credit Facility [Line Items]

Debt issuance costs, net

935,000

Proceeds from credit agreement

$ 1,500,000

Proceeds from credit agreement, additional draw

$ 1,000,000

Senior unsecured notes

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 25,000,000

Debt instrument, term

5 years

Debt instrument, interest rate, stated percentage

6.625%

6.625%

Amount of funds accessed in period

$ 23,900,000

Redemption price, percentage

100.00%

Notes payable, outstanding gross of unamortized issuance costs

$ 25,000,000

$ 25,000,000

Mortgages | Loan Agreement | American Insurance Acquisition

Line of Credit Facility [Line Items]

Debt instrument, term

10 years

Secured Debt | Credit Agreement

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 3,000,000

Debt instrument, term

24 months

Interest accrued to fund loan

0.12

Possible increased to interest accrued to fund loan

0.14

Unamortized debt discount

143,000

Credit agreement, fair value of liability portion

$ 367,000

Balance allocated to equity

$ 133,000

Secured Debt | Credit Agreement | Debt Tranche One | Sheridan Road Partners, LLC

Line of Credit Facility [Line Items]

Debt instrument, face amount

2,000,000

Secured Debt | Credit Agreement | Debt Tranche Two

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 1,000,000

Secured Debt | Credit Agreement | Debt Tranche Three

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 500,000

Secured Debt | Credit Agreement | Debt Tranche Three | Sheridan Road Partners, LLC

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 2,000,000

Secured Debt | Credit Agreement | Debt Tranche Three | Sheridan Road Partners, LLC | Subsequent Event

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 2,000,000

Secured Debt | Credit Agreement | Debt Tranche Four | Sheridan Road Partners, LLC | Subsequent Event

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 1,000,000

Notes Payable - Liability and E

Notes Payable - Liability and Equity Components of Credit Agreement (Details) $ in Thousands	Dec. 31, 2021USD ($)
Line of Credit Facility [Line Items]
Carrying amount of equity component	$ 81
Credit Agreement | Secured Debt
Line of Credit Facility [Line Items]
Principal amount	367
Unamortized debt discount	(143)
Net carrying amount	$ 224

Notes Payable - Debt Outstandin

Notes Payable - Debt Outstanding (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Apr. 26, 2017	Nov. 10, 2016
Line of Credit Facility [Line Items]
Notes payable, outstanding gross of unamortized issuance costs	$ 33,174	$ 36,464
Total notes payable	33,102	36,168
Unamortized issuance costs	$ (72)	(296)
Revolving Credit Facility
Line of Credit Facility [Line Items]
Debt instrument, interest rate, stated percentage	0.01%
Notes payable, outstanding gross of unamortized issuance costs	$ 0	4,601
Credit Agreement
Line of Credit Facility [Line Items]
Debt instrument, interest rate, stated percentage	12.00%
Notes payable, outstanding gross of unamortized issuance costs	$ 224	0
Senior unsecured notes
Line of Credit Facility [Line Items]
Debt instrument, interest rate, stated percentage	6.625%		6.625%
Notes payable, outstanding gross of unamortized issuance costs	$ 25,000	25,000
American Insurance Acquisition | Loan Agreement | 5.0% Mortgage due November 10, 2026
Line of Credit Facility [Line Items]
Debt instrument, interest rate, stated percentage	5.00%			5.00%
Notes payable, outstanding gross of unamortized issuance costs	$ 7,950	$ 6,863

Deconsolidation and Discontin_3

Deconsolidation and Discontinued Operations Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)
Discontinued Operations and Disposal Groups [Abstract]
Notes receivable	$ 18,017	$ 18,017
Interest Rate, increase on unpaid principal balance	0.02
Maximum variable interest rate	0.10
Recognized gain from deconsolidation	$ 126

Deconsolidation and Discontin_4

Deconsolidation and Discontinued Operations Loss From Discontinued Operations, Net of Tax (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Other income	$ 7	$ 0
Global Liberty | Discontinued operations, held-for-sale
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Net premiums earned	7,765	13,908
Net investment loss	(106)	(102)
Net realized gains (losses)	155	(1,411)
Total revenue	7,821	12,395
Net claims incurred	5,980	689
Acquisition costs	(280)	6,875
Other underwriting expenses	1,956	5,117
Interest income	0	(2)
Total expenses	7,656	12,679
Income (loss) from operations before income taxes	165	(284)
Income tax benefit	0	(522)
Net income	165	238
Changes in net unrealized investment gains	(21)	161
Reclassification to net (loss)	(175)	(155)
Other comprehensive (loss) income	(196)	6
Total comprehensive (loss) income	$ (31)	$ 244

Deconsolidation and Discontin_5

Deconsolidation and Discontinued Operations Consolidated Statements of Financial Position (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Liabilities
Total liabilities	$ 0	$ 60,407
Fixed income securities at fair value, amortized cost	$ 0	4,315
Global Liberty | Discontinued operations, held-for-sale
Assets
Fixed income securities, available for sale, at fair value (amortized cost $0,000 and $4,315)		4,544
Other investments		1,319
Total investments		5,863
Cash and cash equivalents		3,029
Accrued investment income		29
Reinsurance recoverables on amounts paid		581
Reinsurance recoverables on amounts unpaid		31,958
Prepaid reinsurance premiums		9,739
Deferred policy acquisition costs		637
Other assets		2,049
Total assets		53,885
Liabilities
Claims liabilities		38,499
Unearned premium reserves		14,545
Due to reinsurers		10
Other liabilities and accrued expenses		7,353
Total liabilities		$ 60,407

Going Concern (Details)

Going Concern (Details)	Apr. 26, 2017USD ($)
Senior unsecured notes
Debt Instrument [Line Items]
Debt instrument, face amount	$ 25,000,000

Subsequent Events Narrative (De

Subsequent Events Narrative (Details) - Subsequent Event $ in Millions	Mar. 25, 2022USD ($)	Jan. 04, 2022
Subsequent Event [Line Items]
Portion of debt used for restructuring activities		0.9183
Portion of debt used for restructuring activities, par amount		0.9934
Credit Agreement, Delayed Draw | Secured Debt
Subsequent Event [Line Items]
Debt instrument, face amount	$ 1

Uncategorized Items - afh-20211

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	$ 23,859,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	$ 7,712,000